Method of manufacturing biocalcified article, and article thereof

By curing a mixture of aggregate and binder to form a self-supporting pre-calcified article and performing biocalcification through immersion or humidification, the method addresses the limitations of existing biocalcification methods, enhancing throughput and uniformity of mechanical properties.

GB2706114APending Publication Date: 2026-11-11CRESCO BIOTECH LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
GB2025005734
Authority / Receiving Office
GB · GB
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-04-16
Publication Date
2026-11-11

AI Technical Summary

Technical Problem

Existing biocalcification methods for constructing materials are limited by the need for complex and expensive systems, such as pumps and specialized molds, leading to low throughput, uneven distribution of mechanical properties, and biofouling issues.

Method used

A method involving a mixture of aggregate, binder, and bacterial inoculant is applied to a mold, cured to form a self-supporting pre-calcified article, which is then subjected to biocalcification through immersion in a calcification solution or humidification, eliminating the need for pumps and molds, and ensuring uniform distribution of calcium carbonate throughout the article.

Benefits of technology

This approach increases throughput, reduces energy consumption, and achieves more uniform mechanical strength and consistent properties across the article, while avoiding biofouling and reducing CO2 emissions.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

A method of manufacturing a biocalcified article, comprising providing a mixture comprising aggregate, a first binder, and a bacterial inoculant, applying the mixture to a mould and curing the mixture
Need to check novelty before this filing date? Find Prior Art

Description

Field of the Invention The present invention relates to methods of making articles, such as panels, and particularly, to biocalcification processes for manufacturing articles. Background It is well-known that concrete and cement are at the core of the construction industry. There are many benefits associated with using these materials for construction such as strength and durability. However, the production of concrete and cement is responsible for around 8 to 10% of global carbon dioxide emissions and requires significant amounts of energy. Use of such materials is therefore generally considered to be unsustainable. There has been growing interest in developing ‘greener’ alternatives to concrete and cement for example by reducing emissions and energy demands. Biomineralization is one such promising alternative for producing ‘greener’ construction materials. “Biomineralization" refers to the production of minerals by living organisms. Known biomineralization processes can produce minerals such as silicates (e.g., opal), carbonates (e.g., calcite), and phosphates (hydroxyapatite). Biocalcification is of particular interest because calcium carbonate (the primary product of most biocalcification processes) is widely used in cement. The process can be performed by microbes and in such cases may be referred to as “microbially induced calcite precipitation", or otherwise “MICP’ in the field. Known MICP methods for manufacturing articles (e.g., parts for construction) involve preparing a mixture suitable for MICP, packing and pressure-sealing said mixture into a mould of a predetermined article shape, and pumping a fluid (comprising components for inducing MICP) through the mould until a desired amount of calcification has developed on the article. WO 2023 / 099925 is one such example that reflects many of the standard practices in the field. It describes for example providing a mixture of aggregate and bacterial inoculant, applying the mixture to a mould, and flowing a ‘calcification solution’ (cementation solution, suitable for bacteria to consume for performing MICP) through the mould. This typically requires connecting pumps to the mould, via fluid inlets and outlets, and then pumping the calcification solution through the mould. As the calcification solution passes through the mould, biocalcification can occur and calcium carbonate precipitates can form, to ultimately produce an article. When fluid-permeable moulds are used, fluid may be pumped through the mould (and thereby through the ‘mould-bound’ mixture) for example by applying pressure across a surface of the mould. Known methods are limited in scale and applicability because they require expensive and complex systems (e.g., pumps, and specialised moulds for pressure sealing). Additionally, the calcification process using these methods can take several days. Another possible problem encountered with known methods is ‘biofouling’, whereby bacteria are flushed out (by pumping) from the mould and into machinery (e.g., pump outlets). This can lead to deleterious and unproductive biocalcification, which may block the flow of calcification solution and increase the need for maintenance of machinery. Yet further, biofouling reduces an amount of bacteria present in the mould, so ‘re-inoculation’ with additional bacteria may be required. It is therefore desirable to provide alternative MICP methods in particular which address one or more of the problems outlined above. The present invention has been devised in light of the above considerations. In particular, the present invention aims to provide an MICP method that is simpler or provides a higher throughput. Summary of the Invention In a general aspect, the present invention relates to a biocalcified article, as described herein, methods of making the biocalcified article, and articles thereof. In a first aspect there is provided a method of manufacturing a biocalcified article. The method comprises providing a mixture; then applying the mixture to a mould, curing the mixture to provide a pre-calcified article; removing the pre-calcified article from the mould; and performing biocalcification to provide a biocalcified article. The mixture comprises aggregate, a first binder, and a bacterial inoculant. In this way, the method of manufacturing can be operationally simpler, less energy-intensive and have a higher throughput than known methods. In known methods, (bio)calcification (MICP) is performed in a mould because known bacterial inoculant-aggregate mixtures typically have insufficient strength for retaining their form (the shape imparted by the mould) before biocalcification is complete. That is, prior to MICP, the mixtures are not necessarily self-supporting and may be deformed by flow of the calcification solution, so a mould is needed for them to retain their form. The incorporation of a binder into the mixture in the present invention allows the mixture to form a self-supporting structure after initial curing (i.e. the pre-calcified article is formed, which can support its own weight under gravity). This can obviate the need for the mould during biocalcification, increasing mould throughput and overall method throughput. Known methods typically require pumps so that the calcification solution can sufficiently penetrate the (mould-bound) mixture, for the article to exhibit adequate properties for purpose (e.g., at least being self-supporting, and typically meeting a minimum mechanical strength threshold for application, for example as a construction part). As well as increasing an amount of biocalcification, pumping the calcification solution can increase a rate of biocalcification. However, even with pump use, known methods can take several days, reducing mould throughput and overall method throughput. It has been surprisingly found that by performing biocalcification on a ‘pre-calcified article’ (corresponding to the self-supporting mixture having a hardened and stabilized matrix, discussed further below) rather than known mixtures (which are not self-supporting), pumps are not required to achieve adequate penetration during the calcification step, or to achieve a threshold amount of calcification within a given timeframe. That is, in the present invention, the biocalcification step does not require pumping and may rely on, for example, diffusion and / or hydrostatic pressure to produce articles with similar or improved properties compared to known articles. In this way, methods of the present invention are operationally simpler because such complex pump-mould systems are not required. The non-reliance on pumps can also reduce energy demands and CO2 emissions compared to known methods. Known MICP methods may produce articles with an uneven distribution of mechanical properties across a length of the article. It is thought that this results from an uneven flow of the calcification solution through the mould, leading to an uneven rate of and amount of MICP throughout the article. Uneven flow, and in turn uneven MICP, may be due to mould shape and size and due to fluid dynamics. Such inhomogeneity may be inevitable in existing methods, because MICP can initiate in a staggered fashion throughout the mould, initiating first proximal to the inlets and initiating last proximal to the outlets. The uneven flow may also lead to reduced MICP proximal to the core of the mixture, or otherwise in regions of poor fluid flow, further diminishing overall mechanical strength and reducing method reliability (i.e., consistent production of articles). It is proposed that carrying out the calcification step (e.g., immersion) on a self-supporting “precalcified article” (i.e., when de-moulded) enables MICP to occur across all surfaces of the article at a more consistent rate while the pre-cured article is immersed in the calcification solution. That is, the method of the present disclosure is thought to produce articles with an improved distribution of MICP, and therefore a more uniform mechanical strength across a length of the article. In other words, methods of the present disclosure are thought to produce articles more reliably (with increased consistency and with more consistent properties). It is also proposed that the present methods may also provide articles with complex shapes, which are inaccessible according to known methods or for which known methods provide inacceptable reliability and / or variation in mechanical strength (e.g. compressive strength). As used herein, the term “biocalcified article" refers to an article or element comprising calcite produced using MICP. The form (shape) of such articles is not particularly limited and may be for example a panel, tile, column, block, or any other shape. Preferably, the biocalcified article is a panel or tile. The biocalcified article may also be referred to as a construction element, in consideration of the possible function and application of the articles. The term “aggregate" is understood in the art and refers to granular materials suitable for ‘bulking up’ the mixture. The aggregate material included in the mixture are not particularly limited. Suitable aggregates are known in the art and may include for example inorganic aggregates such as gravel or stone, and / or biogenic aggregates such as hemp hurds or straw. The aggregate is typically but not necessarily the largest component of the mixture, pre-calcified article, and biocalcified article by at least weight and / or volume. As used herein, the term “binder1’ refers to a substance which can be cured to cement the aggregate and other components of the mixture together to form a self-supporting structure (an article). The binder is not particularly limited in structure, and may be for example a cement (e.g., gypsum plaster) or a polymer. The term “curing" is known in the art and refers to the process of matrix formation and stabilization (hardening) of the binder through for example polymerisation or crystallisation. After curing, the binder may be also referred to as a “cured binder1’ or “hardened matrix". The binder should at least be suitable for curing under conditions (e.g., temperature, pH, and moisture content) which are compatible with survival of the bacteria present as part of the bacterial inoculant. As used herein, the term “bacterial inoculant’ refers to a component comprising bacteria. The bacteria are living and suitable for precipitating calcite by a MICP process, for example in the immersion step defined below. The species of bacteria present in the bacterial inoculant are not particularly limited, with the proviso that they must be capable of performing MICP when environmental conditions (e.g., temperature) are suitable for MICP and all components for MICP are present. In other words, the bacteria of the inoculant may be dormant until activated (until conditions for MICP are met, for example until nutrients and / or a calcium ion source are provided). The bacteria may also be viable, meaning that they are also capable of proliferation when activated. The bacterium Sporacina Pasteurii is an example of a bacteria suitable for the bacterial inoculant. The bacterial inoculant may vary in format, and may for example be a paste, powder (produced by freeze-drying bacteria cells), or encapsulated bacteria. The term “pre-calcified article" refers to the mixture after curing, whereby a self-supporting structure (article) is formed. That is, the pre-calcified article, for example block or panel, can retain its shape without external support. The pre-calcified article comprises cured binder (hardened matrix), bacterial inoculant, and aggregate. In the pre-calcified article, the bacterial inoculant and aggregate are positionally fixed because the binder is cured. The term “precalcified’ is used to indicate that biocalcification (MICP) has not been performed on the article. In other words, after performing biocalcification, the article is no longer referred to as a precalcified article. The term “mould’, as used herein, is well-understood in the art and as used herein refers to a cavity or framework for shaping a material. The mould is not particularly limited in type, size, shape, or material, with the proviso that it is suitable for curing the mixture. For example, if elevated temperatures are required for curing, the mould should be suitably heat resistant for use at the elevated temperature. The mould may be unitary, or may comprise multiple parts, for example a base for applying the mixture to and a top for pressing the mixture for the mixture to adopt a predetermined shape (i.e., the shape of the mould cavity or framework). In use, a mixture may be applied to the mould, for example by inserting the mixture into a mould cavity. After curing, the pre-calcified article can be removed from the mould. For example, when the mould comprises a base and a lid, the pre-calcified article may be removed from the mould by separating the lid to expose the pre-calcified article, and then separating the article from the mould base. In some embodiments, the mould may therefore be flexible. As used herein, the term “biocalcified article" refers to the (pre-calcified) article after biocalcification is performed. That is, when an acceptable amount of calcium carbonate has precipitated on the article, the article may be referred to as a biocalcified article. An acceptable amount of calcium carbonate may be precipitated for example when the article meets a minimum threshold of mechanical strength (e.g., compressive strength). The biocalcified article may subsequently be used as a construction element, for example as a panel for construction. Performing biocalcification (biocalcification step) refers to the process of using MICP to incorporate calcium carbonate into the article, depositing the calcium carbonate throughout the ‘skeleton’ of the article and upon external surfaces of the article (e.g., to form a calcium carbonate ‘shell’). After biocalcification, the article may be referred to as a biocalcified article. There are several means for performing biocalcification. As understood in the art, bacteria must be present for performing MICP, and nutrients and MICP resources (such as calcium ions or a source thereof) must be available for the bacteria. Bacteria are described further below. Biocalcification may be performed by immersion or humidification as described herein, or by any other suitable method. In some embodiments biocalcification may be performed by immersing the pre-calcified article in a calcification solution to provide a biocalcified article. As used herein, the terms “immersion" and “immersing" refer to a process of submerging an object in a liquid. The term “calcification solution" refers to a liquid comprising components for the bacteria of the bacterial inoculant (i.e., bacteria capable of MICP) to perform microbially induced calcite precipitation. It may also be referred to as a biocalcification solution. The exact composition of the calcification solution may vary and may comprise a calcium ion source (e.g., calcium chloride), a urea source (e.g., urea), and / or nutrients for the bacteria to metabolize (e.g., yeast extract). Therefore, in some embodiments, the method may comprise: providing a mixture comprising: aggregate, a first binder, and a bacterial inoculant; applying the mixture to a mould; curing the mixture to provide a pre-calcified article; removing the pre-calcified article from the mould; and immersing the pre-calcified article in a calcification solution to provide a biocalcified article. Alternatively, some embodiments may comprise performing humidification. The term “humidification" refers a process of keeping the pre-calcified article in a humidity-controlled environment (e.g., a humidity-controlled chamber). The humidity-controlled environment should have a humidity high enough for MICP to occur. For example, a (relative) humidity level should be sufficient for water vapour to condense on the article if the mixture for making the article has a low water content, or for the article to retain water for biocalcification if the mixture used for making the article has a high water content. For example, humidification may be performed at or below dew point of the chamber. In such embodiments, the mixture preferably further comprises a calcification composition as defined below. In this way, biocalcification can occur without using a calcification solution (e.g., without evaporating said solution for condensing onto the pre-calcified article, and without immersion). Advantageously, this can reduce the waste and material consumption of the method. It also reduces a risk of non-productive biocalcification, which could otherwise occur during an immersion step if bacteria are present in the calcification solution (for example by diffusing from the pre-calcified article). Advantageously, in this way, biocalcification may also be performed more readily for articles with low porosity. Therefore, in some embodiments, the method may comprise: providing a mixture comprising: aggregate, a first binder, a bacterial inoculant; applying the mixture to a mould; curing the mixture to provide a pre-calcified article; removing the pre-calcified article from the mould; and performing humidification to provide a biocalcified article. In some embodiments, performing biocalcification comprises immersing the pre-calcified article in a calcification solution. In some embodiments, performing biocalcification comprises humidification. In some embodiments, the first binder and the one or more aggregates are present in a binder-to-aggregate weight ratio of between from 0.03 or more to 2 or less. In some embodiments, the aggregate comprises: one or more inorganic aggregates selected from the group consisting of: sand, gravel, stone, concrete, ceramic, marine shells, or olivine; and / or one or more biogenic aggregates selected from the group consisting of: barley straw, oat straw, wheat straw, soy bean straw, miscanthus straw, rapeseed straw, rye straw, legume straw, millet stalks, cotton stalks, cotton seeds, rice husk, hemp hurds, sunflower husk, wheat husk, barley husk, maize stalks, maize cob, coconut shell, coconut haulm, soy bean hulls, sugarcane bagasse, coconut husk, wood chips, wood shavings, vine pruning, and sawdust; and / or one or more selected from the group consisting: of paper and textiles. In some embodiments, the aggregate comprises one or more inorganic aggregates selected from the group consisting of: sand, gravel, stone, concrete, ceramic, marine shells, or olivine, wherein the one or more inorganic aggregates have a size of between from 0.3 mm or more and 24 mm or less. In some embodiments, the aggregate comprises limestone. In some embodiments, the aggregate comprises one or more biogenic aggregates selected from the group consisting of: barley straw, oat straw, wheat straw, soy bean straw, miscanthus straw, rapeseed straw, rye straw, legume straw, millet stalks, cotton stalks, cotton seeds, rice husk, hemp hurds, sunflower husk, wheat husk, barley husk, maize stalks, maize cob, coconut shell, coconut haulm, soy bean hulls, sugarcane bagasse, coconut husk, wood chips, wood shavings, vine pruning, and sawdust, wherein the one or more biogenic aggregates have a size of between from 3 mm or more and 40 mm or less. In some embodiments, the binder comprises gypsum plaster. In some embodiments, the mixture further comprises supplementary calcium carbonate, optionally wherein the supplementary calcium carbonate is present in an amount of between 20 wt% or more and 50 wt% or less, based on a total weight of the mixture. In some embodiments, the bacterial inoculant comprises or more bacteria for microbially induced calcium carbonate precipitation. In some embodiments, the one or more bacteria comprise a urease-producing bacterium and a carbonic anhydrase-producing bacterium. In some embodiments, the one or more bacteria comprises Sporosarcina pasteurii, Bacillus megaterium, Bacillus subtilis, Bactillusc, Bactillus licheniformis, Bacillus mucilaginous, Bactillus thuringiensis, Synechocystis sp, Synechococcus sp, Pseudomonas aeruginosa, Escherichia coli, Pseudomonas Stutzeri, Pseudomonas Aeruginosa, and / or Desulfovibrio desulfuricans. In some embodiments, the one or more bacteria is Sporarcina Pasteurii. In some embodiments, the one or more bacteria comprise Sporarcina Pasteurii and Bacillus megaterium. In some embodiments, the bacterial inoculant is present in an amount of greater than 0 wt% and 33 wt% or less based on a total weight of the mixture. In some embodiments, the binder has a pH of 6.5 or more and 8.5 or less. In some embodiments, immersing the biocalcified article in a calcification solution is performed until a weight of the article increases by an amount of 5% or more, based on a dry weight of the pre-calcified article. In some embodiments, the calcification solution comprises nutrients and a calcium ion source. In some embodiments, the calcium ion source comprises a calcium salt, optionally wherein the calcium salt comprises calcium chloride, calcium acetate, and / or calcium lactate. In some embodiments, the nutrients comprise yeast extract, brewer’s yeast, sodium chloride, ammonium sulphate, dextrose, sucrose, nickel chloride, or a mixture thereof, optionally wherein the nutrients comprise yeast extract. In some embodiments, the calcification solution comprises: nutrients at a concentration of 20 g / L or less and 0.05 g / L or more; and / or a calcium ion source at a concentration of 0.01 M or more and 1.2 M or less. In a second aspect there is provided a method of manufacturing a multilayered biocalcified article. The method comprises providing or manufacturing a biocalcified article according to the first aspect, using two or more mixtures. The second mixture is different from the first mixture. The first mixture may be applied to a mould to provide a first layer, and the second mixture may be layered on (disposed on) the first layer to provide a second layer. In this way, the article may comprise a first layer having a first set of properties, and a second layer having a second set of properties, which may improve applicability of the article. In some embodiments, the method may comprise: providing a first mixture comprising: aggregate, a first binder, and a bacterial inoculant; providing a second mixture comprising: aggregate, a second binder, and a bacterial inoculant; wherein the second mixture is different from the first mixture; applying the first mixture to a mould to provide a first layer; applying the second mixture to the first layer to provide a second layer; curing the mixtures to provide a pre-calcified article; removing the pre-calcified article from the mould; and performing biocalcification to provide a multilayered biocalcified article. The second mixture differs from the first mixture in composition. The second mixture may differ from the first mixture for example by aggregate (type and / or size), binder, bacterial inoculant, or by any additives that may be present as part of the mixture. Preferably, the second mixture differs by at least one of aggregate, binder, and bacterial inoculant. In some embodiments, the mixtures may differ by aggregate. For example, the first or second mixture may comprise an inorganic aggregate, and the other respective mixture may comprise a biogenic aggregate. The first and second layers may differ in amount and / or in thickness or may be the same in amount and / or thickness. For example, a second layer thickness may be equal to the first layer thickness, larger than the first layer thickness, or smaller than the first layer thickness. In a third aspect there is provided a biocalcified article. The biocalcified article comprises aggregate, a cured binder, and calcium carbonate. The cured binder and aggregate may be as defined for the first aspect. At least some of the calcium carbonate is formed by MICP (by biocalcification). In some embodiments, the calcium carbonate may be a calcium carbonate matrix. The term “calcium carbonate matrix" refers to a continuous or semi-continuous network of calcium carbonate formed at least partially by performing biocalcification. In some embodiments, the biocalcified article may comprise aggregate in an amount of 5 wt% or more, preferably 25 wt% or more, more preferably 33 wt% or more, even more preferably 50 wt% or more, based on a total weight of the biocalcified article. In some embodiments, the aggregate may be present in an amount of 97 wt% or less, preferably 85 wt% or less, more preferably 80 wt% or less, based on a total weight of the biocalcified article. In some embodiments, the aggregate may be present in an amount of between 5 wt% or more and 97 wt% or less, based on a total weight of the biocalcified article, preferably between 25 wt% or more and 85 wt% or less, more preferably between 33 wt% or more and 85 wt% or less, even more preferably between 50 wt% or more and 80 wt% or less, most preferably between 50 wt% or more and 80 wt% or less. It is also thought that articles according to the present invention may have improved breathability, which can be relevant for applications where moisture regulation standards must be met (for example, when an article is used in construction). In some embodiments, the biocalcified article may have a water vapour transmissibility (p) of 17 or less, preferably 16 or less, and more preferably 15 or less when measured according to ISO 12572:2016. In this way, breathability may particularly high. Water vapour transmissibility may be controlled by adjusting porosity of the biocalcified article, for example by controlling aggregate size and type, binder, aggregate-to-binder ratio, and other features as described herein. Preferably, when the biocalcified article has a water vapour transmissibility of 17 or less, it also comprises aggregate in amounts defined above (e.g., in an amount of between 5 wt% or more and 97 wt% or less), and / or a porosity as defined below. In some embodiments, the biocalcified article may have a porosity (permeable void space volume) of between from 2% to 50%, wherein porosity is measured according to ASTM C642-06. When the biocalcified article has a porosity of 2% to 50%, it preferably also has a water vapour transmissibility of 17 or less, and preferably also comprises aggregate in amounts defined above. In some embodiments, the biocalcified article may comprise spent bacterial inoculant. “Spent bacterial inoculant’ refers to bacterial inoculant which has been used for performing biocalcification. The biocalcified article does not necessarily comprise spent bacterial inoculant, for example because residual (spent) bacterial inoculant from manufacturing may be removed, for example by washing. The biocalcified article may be made according to the methods of the present invention. Therefore, in some embodiments, the biocalcified article may be produced according to the first aspect. That is, there may be provided a biocalcified article produced according to the method of producing a biocalcified article according to the first aspect. As discussed above, it is thought that such articles can be produced more reliably by methods according to the first aspect, because they may have a more even distribution of properties, owing to a more even distribution of MICP during the biocalcification step. In some embodiments, the biocalcified article may be a multilayered biocalcified article comprising a first layer and a second layer, wherein each layer comprises aggregate, a cured binder, and calcium carbonate, wherein the first layer is different from the second layer. In some embodiments, the biocalcified article may be a multilayered biocalcified article produced according to the second aspect. In a fourth aspect there is provided a pre-calcified article. The pre-calcified article comprises aggregate, a bacterial inoculant, and a cured binder agent. The cured binder and aggregate may be as defined for the first aspect. The pre-calcified article may be made by the methods described for the first aspect. Therefore, in some embodiments, the pre-calcified article may be produced according to the first aspect. That is, there may be provided a pre-calcified article produced by providing a mixture comprising: aggregate, a first binder, a bacterial inoculant; applying the mixture to a mould; and curing the mixture to provide a pre-calcified article. Advantageously, such articles may be subject to biocalcification without complex systems (e.g., known systems using pumps) and without the need for a mould, and the article may be produced with a high throughput. In some embodiments, the pre-calcified article may have a porosity of between from 4% to 55%, wherein porosity is measured according to ASTM C642-06. The pre-calcified article has a higher porosity than the biocalcified article. In some embodiments, there may be provided a pre-calcified article produced according to the second aspect. Detailed Description of the Invention The present invention provides a method of manufacturing a biocalcified article, a method of manufacturing a multilayered article, and articles thereof for each method. First Aspect The first aspect of the invention is a method of making a biocalcified article. The method comprises providing a mixture; then applying the mixture to a mould, curing the mixture to provide a pre-calcified article; removing the pre-calcified article from the mould; and performing biocalcification to provide a biocalcified article. The mixture comprises aggregate, a first binder, and a bacterial inoculant. Performing Biocalcification - Immersion in Calcification Solution After the pre-calcified article is removed from the mould, biocalcification is performed. In some embodiments, biocalcification may be performed by immersing the pre-calcified article in a calcification solution to provide a biocalcified article. This process may be specifically referred to as the immersion step, or more generally as calcification step, biocalcification step, or MICP step. Immersion is performed for the bacteria present in the bacterial inoculant to precipitate calcium carbonate. They may precipitate calcium carbonate (perform MICP) because the article is immersed in a calcification solution, which provides components for performing MICP. Bacteria are present as part of the pre-calcified article, so calcite precipitates may form between aggregate particles, and between the aggregate and stabilized matrix (cured binder). In other words, during immersion, calcium carbonate may be deposited on and between surfaces of the pre-calcified article. The calcium carbonate precipitate further cements the components of the article together and mechanically strengthens the article. The apparatus for performing immersion are not particularly limited, and may comprise for example a bath, tank, or chamber comprising the calcification solution. In practice, immersion may be performed using a chamber or bath comprising the calcification solution. In this way, biocalcification may occur throughout an article without a need for pumping. Instead, diffusion of the calcification solution is thought to occur across all (exposed) surfaces of the article, enabling penetration of the calcification solution throughout the article, thereby providing adequate or even improved amounts and rates of calcification (MICP) compared to known methods. Calcification can also occur more evenly throughout articles, which may afford articles with more homogeneous mechanical strength (e.g., compressive strength). Immersion may be performed until a predetermined condition is met, for example until an amount of biocalcification (MICP) on an article is acceptable (e.g., until all exposed surfaces of the article are visually covered in calcium carbonate), or until another condition is met. In methods of the present disclosure, the biocalcification solution is not required to comprise bacteria suitable for MICP, because bacteria are present in the pre-cured article. However, in some embodiments the biocalcification solution may comprise bacteria suitable for MICP. In some embodiments, performing biocalcification comprises immersing the pre-calcified article in a calcification solution. In some embodiments, immersing the pre-calcified article may comprise submerging the precalcified article in the calcification solution. The pre-calcified article may be partially or fully immersed (submerged) in the calcification solution. Preferably, the entire pre-calcified article is fully submerged in the calcification solution, because this can increase the rate of calcification, thereby reducing a duration of the immersion step. This can also reduce variations in mechanical strength along a length of the biocalcified article, increasing method reliability. In some embodiments, immersion may comprise submerging the (pre-calcified) article at a predetermined depth, for example a depth of 50 cm or more, preferably 75 cm or more, and more preferably 100 cm or more. A depth of the article may refer to the minimum Euclidian distance between the article and the surface of the calcification solution. In this way, hydrostatic pressure acting on the article may be increased for improving penetration of the calcification solution through the article, thereby improving a rate and amount of calcium carbonate formation. To further increase penetration of the calcification solution through the article, several steps may be taken. In some embodiments, the calcification solution is aerated during the immersion step. Aeration may comprise bubbling air or oxygen through the calcification solution. This can improve proliferation of the bacteria present as part of the article, improving a rate of calcification. Additionally, or alternatively, aeration may comprise removing the article from the calcification solution and re-immersing it in the calcification solution. Additionally or alternatively, the calcification solution may be agitated. For example, the calcification solution may be mechanically stirred, and / or oxygen may be bubbled through the solution. Oxygen may be pure, or provided as a gaseous mixture (e.g., air). In some embodiments, performing calcification may comprise agitating or stirring the calcification solution. In this way, calcification solution homogeneity may be improved during the immersion step, which in turn is thought to reduce variations in rates and amounts of precipitation at different positions of the article. In some embodiments, immersion may be performed at a temperature of between 5 °C or more and 50 °C or less, to fine-tune a rate of calcium carbonate precipitation and penetration of the calcification solution through the article. A temperature for the immersion step may be determined by measuring a temperature of the calcification solution and may be controlled for example using a temperature-controlled chamber, tank, or bath. Preferably, the immersion step is performed at a temperature of between 15 °C or more and 40 °C or less, more preferably at a temperature of between 20 °C or more and 30 °C or less, most preferably at a temperature of between 23 °C or more and 27 °C or less. In some embodiments, immersion may be performed at a temperature of 5 °C or more, preferably 15 °C or more, more preferably 20 °C or more, and most preferably 23 °C or more. In some embodiments, immersion may be performed at a temperature of 50 °C or less, preferably 40 °C or less, more preferably 30 °C or less, and most preferably 27 °C or less. Immersion may be performed until a predetermined condition is met. The predetermined condition is not particularly limited and may depend on an intended application of the biocalcified article. In this way, immersion may be performed until a desirable amount of biocalcification (MICP) has occurred, and a balance of mechanical strength and weight of the biocalcified article may be fine-tuned. In some embodiments, immersion may be performed until the article has a compressive strength of 2 MPa or more, 3 MPa or more, 4 MPa or more, 5 MPa or more, 6 MPa or more, 10 MPa or more, 15 MPa or more, or 20 MPa or more, wherein compressive strength is measured according to the method of the description. In some embodiments, immersion may be performed until a concentration of a component of the calcification solution decreases by a minimum threshold amount. For example, immersion may be performed until a calcium ion concentration of the calcification solution decreases by 10% or more, 20% or more, 30% or more, or 40% or more, based on an initial calcium ion concentration of the calcification solution. Component concentration may be measured by any suitable means, such as titration. Alternatively, in some embodiments, immersion may be performed until a concentration of a component of the calcification solution decreases to a threshold amount or lower. For example, immersion may be performed until a calcium ion concentration of the calcification solution is 450 mM or lower, 400 mM or lower, 350 mM or lower, or 300 mM or lower. In this way, the measured value (e.g., absolute concentration or decrease in concentration) may indicate that an acceptable amount of MICP has occurred for a particular set of method conditions. In some embodiments, immersion is performed until a dry weight of the article increases by an amount of 5% or more, based on a dry weight of the pre-calcified article. In some embodiments, immersion is performed until a dry weight of the article increases by an amount of 35% or less, based on a dry weight of the pre-calcified article. In some embodiments, immersion is performed until a dry weight of the article increases by an amount of between from 5% or more and 35% or less, based on a dry weight of the pre-calcified article. When the aggregate is inorganic aggregate, immersion is preferably performed until a dry weight increases by between 5% or more and 20% or less. When the aggregate is biogenic aggregate, immersion is preferably performed until a dry weight of the article increases by an amount of between 10% or more and 35% or less. A dry weight of the pre-calcified article may refer to the weight of the precalcified article upon removal from the mould, before biocalcification is performed. A dry weight increase of the article may be determined by measuring an initial weight of the pre-calcified article prior to immersion (e.g., upon removal from the mould), and periodically re-weighing the article during immersion. This may comprise removing the article from the calcification solution, drying the article, and making another weight measurement for comparing to the initial weight. The pressure and duration for drying the article are not particularly limited, providing that bacteria can perform MICP after re-immersion. The temperature for drying is preferably a “biological temperature" as defined herein, to reduce a risk of bacterial cell death. In some embodiments, drying may be performed for a duration of 24 hours or less, optionally at a temperature of 40 °C or less. Alternatively, performing immersion until a weight of the article has increased by a minimum amount or more may comprise measuring the weight of the article without removing the article from the calcification solution. For example, the pre-calcified article may be immersed and disposed on a submerged weight measurement device (e.g., scale). In such embodiments, an initial weight measurement may be taken after disposing the pre-calcified article on a submerged weight measurement device, and immersion may continue until the weight increases by a minimum threshold or more (e.g., 5% or more, based on the initial submerged weight of the article). In some embodiments, immersion is performed until a weight of the article increases by 7% or more, 10% or more, 15% or more, 20% or more, 25% or more, or 30% or more based on an initial submerged weight of the pre-calcified article or based on an initial dry weight of the precalcified article. In some embodiments, immersion may be performed until compressive strength of the article increases by two times or more, preferably by 3 times or more, more preferably by 4 times or more, even more preferably by 5 times or more, and most preferably by 8 times or more, based on a ratio of the biocalcified article compressive strength and the pre-calcified article compressive strength. An increase in compressive strength for a particular composition of mixture and for a particular set of calcification conditions (e.g., temperature) may be determined by comparing compressive strength of a sample after removal from the mould, and again after immersion. In some embodiments, immersion may be performed for a predetermined amount of time. In some embodiments, the predetermined amount of time may be 240 hours or less, 200 hours or less, 160 hours or less, 120 hours or less, 80 hours or less, 64 hours or less, 48 hours or less, 42 hours or less, 36 hours or less, 30 hours or less, 24 hours or less, 18 hours or less, 12 hours or less, or 6 hours or less. Generally, shorter durations are preferred for increasing method throughput. In some embodiments, immersion may be performed for a duration of 15 minutes or more, 30 minutes or more, 60 minutes or more, or 90 minutes or more. In this way, an amount of MICP can be increased. It is proposed that immersion duration (and more generally, biocalcification duration) may be independent of article size and shape for many articles, because immersion or humidification (according to the present disclosure) can facilitate biocalcification across an all areas of article simultaneously (e.g., due to increased surface area contact between a calcification solution and the article). Calcification Solution for Immersion Step The calcification solution is a liquid comprising components for the bacteria of the bacterial inoculant to perform MICP. In other words, the calcification solution may comprise nutrients (e.g., yeast extract) and / or sources of components needed for the MICP process (e.g., a carbonate source). In some embodiments, the calcification solution comprises nutrients and a calcium ion source. The nutrients and calcium ion source are not particularly limited. Examples of suitable nutrients are known in the art and may include for example yeast extract, brewer’s yeast, sodium chloride, ammonium sulphate, dextrose, sucrose, nickel chloride, and mixtures thereof. Accordingly, in some embodiments the nutrients comprise yeast extract, brewer’s yeast, sodium chloride, ammonium sulphate, dextrose, sucrose, nickel chloride, or a mixture thereof. In some embodiments, the nutrients comprise yeast extract. The calcium ion source may comprise a calcium salt. Examples of suitable calcium salts are known in the art and may include but are not limited to calcium chloride, calcium acetate, and calcium lactate. Accordingly, in some embodiments, the calcium salt comprises calcium chloride, calcium acetate and / or calcium lactate. Preferably, the calcium ion source comprises calcium chloride or calcium acetate. In some embodiments, the calcium ion source consists of calcium chloride or calcium acetate. In some embodiments, the calcification solution may further comprise urea. Urea may serve as a supplementary carbonate ion source for promoting MICP, in particular when the bacterial inoculant comprises a urease-producing bacteria. In some embodiments, the amount of nutrients, calcium ion source, and / or urea (if present), may be according to predetermined amounts. In this way, an amount and rate of MICP may be fine-tuned, and an amount of bacteria proliferation may be controlled. In some embodiments, calcification solution comprises nutrients at a concentration of 20 g / L or less, based on a total volume of the calcification solution. Preferably, the calcification solution comprises nutrients at a concentration of 15 g / L or less, more preferably at a concentration of 10 g / L or less, even more preferably at a concentration of 5 g / L or less, and most preferably at a concentration of 1.5 g / L or less. When a concentration of the nutrients is above 20 g / L, a risk of bacteria proliferating in the calcification solution (away from the article) may increase. In some embodiments, the calcification solution comprises nutrients at a concentration of 0.05 g / L or more, more preferably at a concentration of 0.1 g / L or more, even more preferably at a concentration of 0.5 g / L or more, and most preferably at a concentration of 1 g / L or more. In this way, a particularly favourable rate of MICP may occur for shorting the duration of the biocalcification step. In some embodiments, the calcification solution comprises nutrients at a concentration of the calcification comprises nutrients at a concentration of 20 g / L or less and 0.05 g / L or more. In some embodiments, the calcification solution comprises a calcium ion source at a concentration of 0.01 M or more (of Ca2+ ions), based on a total volume of the calcification solution. In this way, the calcification solution may increase a rate of biocalcification, for increasing method throughput. Preferably, the calcification solution comprises a calcium ion source at a concentration of 0.1 M or more, more preferably at a concentration of 0.2 M or more, and most preferably at a concentration of 0.25 M or more. In some embodiments, the calcification solution comprises a calcium ion source at a concentration of 1.2 M or less, preferably at a concentration of 1.0 M or less, more preferably at a concentration of 0.5 M or less, and most preferably at a concentration of 0.35 M or less. By controlling a concentration of calcium ions in this way, a rate of MICP and mechanical strength of the biocalcified article may be further compatibilized. It is thought that a lower calcium ion concentration may reduce a rate of MICP, lowering method throughput but promoting additional penetration of the calcification solution throughout the article, thereby further promoting an even distribution of MICP throughout the article. At higher calcium ion concentrations (above 0.35 M), it is thought that a rate of MICP may correspondingly increase but with an inverse relationship to solution penetration. In some embodiments, the calcification solution comprises a calcium ion source at a concentration of between 0.25 M or more and 0.35 M or less, and nutrients at a concentration of between 1 g / L or more and 1.5 g / L or less. In some embodiments, the calcification solution comprises urea at a concentration of 0.1 M or more, more preferably at a concentration of 0.2 M or more, and most preferably at a concentration of 0.25 M or more, based on a total volume of the calcification solution. In some embodiments, the calcification solution comprises urea at a concentration of 1.2 M or less, preferably at a concentration of 1.0 M or less, more preferably at a concentration of 0.5 M or less, and most preferably at a concentration of 0.35 M or less. Preferably, when the bacteria present as part of the bacterial inoculant comprises a urease-producing bacteria, the calcification solution further comprises urea at a concentration of 0.25 M or more and 0.35 M or less. Performing Biocalcification - Humidification and Calcification Composition In some embodiments, performing biocalcification may comprise humidification. As described above, humidification refers to the process of keeping the pre-calcified article in a humidity-controlled environment for bacteria present in the pre-calcified article to precipitate calcium carbonate for producing the biocalcified article. As such, the process of humidification may involve the condensation of water vapour on the pre-calcified article. Without wishing to be bound by theory, it is thought that by performing humidification on a pre-calcified article, biocalcification may occur more evenly (at more consistent rates and amounts) across an article compared to known methods. This may be because, during humidification, condensation (of water or a calcification solution, for example) may occur at consistent rates across surfaces of the article for further promoting uniform amounts and rates of MICP. It is also thought that high humidity levels can help retain water already present as part of the pre-calcified article (e.g., when supplied as part of the mixture, for example as part of the bacterial inoculant), thereby also promoting consistent MICP throughout an article. When performing biocalcification comprises humidification, the mixture preferably further comprises a calcification composition. In other words, in such embodiments the mixture preferably comprises aggregate, a first binder, a bacterial inoculant, and a calcification composition. The “calcification composition" has a similar function as the calcification solution described herein for embodiments comprising an immersion step. That is, the calcification composition can serve as a source of calcium ions and / or carbonate ions for the bacteria present as part of the bacterial inoculant to perform MICP. The calcification composition as defined above may also be present as part of the mixture when calcification comprises immersion, and may further increase a rate of biocalcification in such embodiments compared to when the pre-calcified article does not comprise a calcification composition. The calcification composition comprises at least a calcium ion source. Suitable calcium ion sources are known and may include calcium chloride, calcium acetate, or calcium lactate. Preferably, the calcium ion source is calcium chloride or calcium acetate. The calcification composition may also comprise a carbonate source. Suitable carbonate sources are known and may include sodium carbonate, ammonium carbonate, or urea. Preferably, in particular when the bacterial inoculant comprises a urease-producing bacterium, the carbonate source is urea. The amount of calcification composition present as part of the mixture is not particularly limited and may be for example 8 wt% or less, based on a total weight of the mixture. It is preferably present in an amount of 7 wt% or less, and more preferably 6 wt% or less, and most preferably 5 wt% or less. In some embodiments, humidification may comprise inserting the pre-calcified article into a chamber, wherein the chamber is at or below the dew point. A dew point is understood in the art and refers to a temperature at or below which liquid droplets may form. It is known that the dew point may change depending on atmospheric pressure and humidity. As used herein, the term “dew point’ does not refer to a frost point, in which ice deposition may occur instead of condensation. An amount of water to be precipitated is not particularly limited, providing that MICP can occur. Therefore, humidification does not necessarily need to be performed at a dew point. In some embodiments, humidification may comprise vaporising water. The vapourised water may then condense onto the article for MICP to occur or may reduce water loss from the article. In some embodiments, humidification may instead comprise vaporising a calcification solution as defined above and below. In this way, a rate and amount of calcification may further increase, because the vapourised solution can carry supplementary nutrients and / or materials for MICP (e.g., a calcium ion source such as calcium chloride, and / or a carbonate source such as urea, and / or yeast extract). In some embodiments, humidification may be performed at a predetermined temperature. The temperature for humidification refers to a temperature of the environment (e.g., chamber) in which humidification is performed. In this way, a rate of calcification may be fine-tuned for adjusting a duration of the biocalcification step. In some embodiments, humidification may be performed at a temperature of 45 °C or less, preferably 42 °C or less, more preferably 39 °C or less. In some embodiments, humidification may be performed at a temperature of 15 °C or more, preferably 25 °C or more, more preferably 33 °C or more. In some embodiments, humidification may be performed at a temperature of between 45 °C or less and 15 °C or more, preferably 42 °C or less and 25 °C or more, more preferably 39 °C or less and 33 °C or more. Humidification may be performed until a predetermined condition is met, as defined above for when biocalcification comprises immersion. For example, humidification may be performed until a compressive strength increases to a minimum threshold. Alternatively, in some embodiments, humidification may be performed until a weight of the article increases by an amount of 5% or more, based on a dry weight of the pre-calcified article. For example, an initial (dry) weight of the pre-calcified article may be measured, and the article may be disposed on a weight measurement device for measurement during the humidification process. Humidification may be performed with the article disposed on a weight measurement device. In this way, weight measurements may be determined more conveniently. Performing biocalcification - Immersion with a Calcification Composition In some embodiments, when the mixture comprises a calcification composition as defined above, it is still possible to perform biocalcification by immersion. In such embodiments, the calcification solution for the immersion step preferably comprises components in lower amounts compared to when a calcification composition is not present. In some such embodiments, the calcification solution may comprise nutrients at a concentration of 2 g / L or less, based on a total volume of the calcification solution. Preferably, the calcification solution comprises nutrients at a concentration of 1.5 g / L or less, more preferably at a concentration of 0.1 g / L or less, even more preferably at a concentration of 0.5 g / L or less, and most preferably at a concentration of 0.15 g / L or less. In some embodiments, the calcification solution comprises nutrients at a concentration of 0.005 g / L or more, more preferably at a concentration of 0.01 g / L or more, even more preferably at a concentration of 0.05 g / L or more, and most preferably at a concentration of 0.1 g / L or more. In some such embodiments, the calcification solution may comprise a calcium ion source at a concentration of 0.001 M or more (of Ca2+ ions), based on a total volume of the calcification solution. Preferably, the calcification solution comprises a calcium ion source at a concentration of 0.01 M or more, more preferably at a concentration of 0.02 M or more, and most preferably at a concentration of 0.025 M or more. In some embodiments, the calcification solution comprises a calcium ion source at a concentration of 0.12 M or less, preferably at a concentration of 0.1 M or less, more preferably at a concentration of 0.05 M or less, and most preferably at a concentration of 0.035 M or less. In some such embodiments, the calcification solution comprises a calcium ion source at a concentration of between 0.025 M or more and 0.035 M or less, and nutrients at a concentration of between 0.1 g / L or more and 0.15 g / L or less. In some such embodiments, the calcification solution comprises urea at a concentration of 0.01 M or more, more preferably at a concentration of 0.02 M or more, and most preferably at a concentration of 0.025 M or more, based on a total volume of the calcification solution. In some embodiments, the calcification solution comprises urea at a concentration of 0.12 M or less, preferably at a concentration of 0.10 M or less, more preferably at a concentration of 0.05 M or less, and most preferably at a concentration of 0.035 M or less. Preferably, when the bacteria present as part of the bacterial inoculant comprises a urease-producing bacteria, the calcification solution further comprises urea at a concentration of 0.025 M or more and 0.035 M or less. In some embodiments, the mixture comprises supplementary calcium carbonate. In such embodiments, the supplementary calcium carbonate may be present in an amount of between from 20 wt% or more and 50 wt% or less, based on a total weight of the mixture. More preferably, the supplementary calcium carbonate is present in an amount of between 30 wt% or more and 50 wt% or less. In this way, a duration for the step of performing biocalcification may be reduced, increasing method throughput. Aggregates The mixture comprises aggregate for ‘bulking up’ the mixture. The aggregate may be any suitable aggregate, for example stone. Aggregate may refer to one or more types of aggregate, for example marble, or for example a mixture of marble limestone. In particular, the aggregate may be or comprise inorganic aggregate or biogenic aggregate, or an alternative aggregate. Inorganic aggregate refers to minerals such as mineraloid particles or rock particles. Biogenic aggregate refers to aggregates from (e.g., produced by) biological sources, such as from plants. Other suitable aggregates are described herein. By providing aggregate, it is thought that an initial rate of MICP during the calcification step may be increased, because aggregate surfaces may function as nucleation points for calcium carbonate precipitation. The aggregate may be selected depending on the intended use of an article. For example, in applications where mechanical strength must meet a minimum standard, aggregates for improving mechanical strength may be selected. In some embodiments, the aggregate may comprise one or more inorganic aggregates. By including an inorganic aggregate, the mechanical strength of the pre-calcified article and / or the biocalcified article may be improved. This may be due to the hardness of inorganic aggregates. Inorganic aggregates are not particularly limited and are known in the art. In some embodiments, the one or more inorganic aggregates may be selected from the group consisting of: sand, gravel, stone (e.g., sandstone, limestone, granite, slate, marble, chalk, basalt, quartzite, dolomite, or quarry fines thereof), concrete, ceramic, marine shells, or olivine (or olivine based materials). In some embodiments, the inorganic aggregates may comprise recycled materials, such as ceramic (e.g., from tiles, sinks, sanitaryware, plates, cups, or other crockery), flagstones, tarmac, asphalt, concrete, bricks, rooftiles, glass, or rubber particulate. When the aggregate comprises limestone, an initial rate of calcium carbonate precipitation may further increase during the calcification step, compared to when the aggregate does not comprise limestone. This is thought to be because of a lower activation energy for nucleation at aggregate surfaces comprising calcium carbonate, compared to other aggregate surfaces, and because limestone comprises calcium carbonate. It is also thought that chemical adhesion between the limestone and precipitated calcium carbonatite may also increase article mechanical strength (e.g., tensile strength). Such improvements to initial rate of calcium carbonate precipitation and adhesion are also thought to be possible when the inorganic aggregate comprises calcium carbonate and is not limestone (e.g., when the inorganic aggregate comprises dolomite). Preferably, the aggregate comprises limestone or a different inorganic aggregate comprising calcium carbonate (e.g., dolomite). More preferably, the aggregate comprises limestone. In some embodiments additionally or alternatively, the aggregate may comprise one or more biogenic aggregates. By including a biogenic aggregate, it is thought that the mixture may be more compressible, which can enable fine control over the mixture density during moulding and curing. This can be used for fine-tuning the pre-calcified article density and balancing it with mechanical strength of the biocalcified article, and for fine-tuning pre-calcified article porosity for improving penetration of the biocalcification solution during immersion (for improving a rate and amount of MICP). Suitable biogenic aggregates are known in the art. In some embodiments, the one or more biogenic aggregates may be selected from the group consisting of: barley straw, oat straw, wheat straw, soy bean straw, miscanthus straw, rapeseed straw, rye straw, legume straw, millet stalks, cotton stalks, cotton seeds, rice husk, hemp hurds, sunflower husk, wheat husk, barley husk, maize stalks, maize cob, coconut shell, coconut haulm, soy bean hulls, sugarcane bagasse, coconut husk, wood chips, wood shavings, vine pruning (e.g., vine pruning chips), and sawdust. Additionally, or alternatively, aggregate other than inorganic aggregate and biogenic aggregate may be used. In some embodiments, the aggregate may comprise one or more selected from the group consisting: of paper and textiles. In this way, a carbon footprint of the method may be reduced, for example when the paper or textiles incorporated into the mixture are recycled materials. In some embodiments, the aggregate may be treated to increase porosity, adhesion to the binder, fire resistance, and / or to reduce compressibility. For example, the aggregate may comprise a flame retardant coating to improve fire resistance and may comprise pores (formed using acid treatment) for improving binder adhesion, and for improving penetration of the biocalcification solution and increased amounts of calcification. These treatments may be performed prior to providing the mixture, which can be produced by mixing the bacterial inoculant, aggregate, binder, and any other components. In some embodiments, the aggregate may have a predetermined size. In the art, aggregate size is understood to mean a longest linear distance between two points on an aggregate particle (i.e., a longest dimension of an aggregate particles). Accordingly, aggregate size may be determined according to BS EN 933 [part 1], for example by sieving aggregates. In some embodiments, the aggregate has a size of between 0.3 mm or more and 40 mm or less. In this way, a favourable balance may be achieved between density and mechanical strength of the biocalcified article. When aggregate size is above 0.3 mm or below 40 mm, penetration of the calcification solution into the article may be particularly effective for embodiments comprising immersion or humidification, which may increase a rate and amount of calcification and increase method throughput. In some embodiments, the aggregate may have a size of below 0.3 mm. When the aggregate is defined according to a size threshold (minimum, maximum, or range), the size may have an error of 5% or less. For example, if 200 g of aggregate has a size of between 0.3 mm or more and 40 mm or less (e.g., according to BS EN 911 [part 1]) and the size has an error of 5% or less, 5 g or less of the aggregate may have a size outside of said range. Preferably, aggregate size has an error of 1% or less. Aggregate size may be controlled by sifting or otherwise filtering aggregate particles using known methods, or by for example milling raw materials until a desired aggregate size is reached. For example, to control an upper limit of aggregate size to be 40 mm or less, a filter with a mesh size of 40 mm can be used, and aggregate particles which pass through the mesh may be collected for use. For example, to control a lower limit of aggregate size to be 3 mm or more, a filter with a mesh size of 2 mm can be used, and aggregate particles which do not pass through the mesh may be collected for use. When the aggregate comprises inorganic aggregate, the inorganic aggregate size is preferably 24 mm or less. In such embodiments, the inorganic aggregate size is preferably 0.3 mm or more. Preferably inorganic aggregate size is between 0.3 mm or more and 24 mm or less. In this way, a particularly favourable mechanical strength of the biocalcified article may be exhibited. When the aggregate comprises biogenic aggregate, the biogenic aggregate size is preferably between 3 mm or more. In such embodiments, the biogenic aggregate size is preferably 40 mm or less. Preferably the biogenic aggregate size is between 3 mm or more and 40 mm or less. Aggregate size is preferably larger for biogenic aggregates compared to inorganic aggregates, because biogenic aggregates are generally more compressible. To elaborate, compression of biogenic aggregates may lead to unfavourable porosity and thus poor calcification solution penetration during immersion if not controlled. In some embodiments, the aggregate may be present in an amount of 5 wt% or more, preferably 25 wt% or more, more preferably 33 wt% or more, even more preferably 50 wt% or more, and most preferably 65 wt% or more, based on a total weight of the mixture. In some embodiments, the aggregate may be present in an amount of 97 wt% or less, preferably 85 wt% or less, based on a total weight of the mixture. In some embodiments, the aggregate may be present in an amount of between 5 wt% or more and 97 wt% or less, based on a total weight of the mixture, preferably between 25 wt% or more and 85 wt% or less, more preferably between 33 wt% or more and 85 wt% or less, even more preferably between 50 wt% or more and 85 wt% or less, most preferably between 65 wt% or more and 85 wt% or less. Binder-to-aggregate weight ratio The binder and aggregate may be present as part of the mixture according to a weight ratio. In this way, it is proposed that mechanical strength of the pre-calcified article may be compatibilized with a reduced risk of adhesion problems during the curing step, where the mixture may adhere to the mould. In some embodiments, the binder and the aggregate may be present in a binder-to-aggregate weight ratio of between 0.03 or more. In some embodiments, the binger-to-aggregate weight ratio is 2 or less. In some embodiments, the binder-to-aggregate weight ratio is between 0.03 or more and 2 or less. Without wishing to be bound by theory, it is proposed that when the ratio is above 0.03, self-supporting (pre-calcified) article can be more readily formed. When the ratio is below 2, it is proposed that there particularly favourable rates of MICP may occur during the biocalcification step. Without wishing to be bound by theory, it is thought that there may be a reduced risk of encasing the bacterial inoculant with the binder. Removal from the mould is also thought to be simpler, because there may be a reduced chance of adhesion between the binder and mould. Generally, a lower amount of binder is preferred to minimise material consumption and to balance mechanical strength of the pre-calcified article with rate of biocalcification during the immersion step. Additionally, when a binder-to-aggregate ratio satisfies the above constraints, it is thought biocalcification may be performed more easily, because the pre-calcified article porosity may be particularly suited for promoting penetration and transport of nutrients and components for MICP throughout the article (e.g., via a calcification composition). When the aggregate consists of inorganic aggregates, the binder-to-aggregate weight ratio is preferably 0.03 or more, and more preferably 0.06 or more. In such embodiments, the binder-to-aggregate weight ratio is preferably 0.22 or less, more preferably 0.16 or less, and most preferably 0.10 or less. In some embodiments, when the aggregate consists of inorganic aggregates, the binder-to-aggregate weight ratio may be between 0.03 or more and 0.22 or less, more preferably between 0.03 or more and 0.16 or less, even more preferably between 0.06 or more and 0.16 or less, and most preferably between 0.06 or more and 0.10 or less. When the aggregate consists of inorganic aggregates and the binder-to-aggregate ratio is below 0.22, the rate of MICP during biocalcification may be particularly favourable and reduced chance of adhesion between the mould and binder is thought to occur. Without wishing to be bound by theory, this is thought to be due to differences in the binding interactions between the binder and inorganic aggregates, compared to between the binder and biogenic aggregates. When the aggregate consists of biogenic aggregates, the binder-to-aggregate weight ratio is preferably 0.5 or more. In such embodiments, the binder-to-aggregate weight ratio is preferably 2 or less, more preferably 1.5 or less, and most preferably 1 or less. In some embodiments, when the aggregate consists of biogenic aggregates, the binder-to aggregate weight ratio is preferably between 0.5 or more and 2 or less, more preferably between 0.5 or more and 1.5 or less, and most preferably between 0.5 or more and 1 or less. When the aggregate comprises inorganic aggregates and biogenic aggregates, a different binder-to-aggregate ratio may be use. This is thought to compatibiilize the materials for curing and biocalcification, depending on the aggregates used. In such embodiments, the binder-to-aggregate weight ratio is preferably 0.03 or more, more preferably 0.2 or more. In such embodiments, the binder-to-aggregate weight ratio is preferably 1 or less, and more preferably 0.5 or less. In some such embodiments, the binder-to-aggregate weight ratio is between 0.03 or more and 1 or less, more preferably between 0.2 or more and 1 or less, and most preferably between 0.2 or more and 0.5 or less from a standpoint of computerizing the materials for curing and biocalcification. After curing the mixture, the resulting pre-calcified article comprises a cured binder. The cured binder may be defined according to a cured binder-to-aggregate weight ratio. The cured binder-to-aggregate weight ratio may be determined according to the binder-to-aggregate weight ratios above. Binders The binder may be any suitable binder for making the mixture self-supporting (for producing a pre-calcified article). Such binders are known in the art and may be of a particular type, for example a particular mineral type. In general embodiments, the binder may comprise one or more selected from: cement, lime, gypsum plaster, alkali activated material (AAM), or polymerizable material. By using a plaster of one or more types as defined above, a curing time may be reduced for increasing method throughput, and curing may be performed at ambient temperature. Cement may refer to one or more types of cement, such as geopolymer cement or calcined clay cement. In some embodiments, cement may comprise one or more selected from the group consisting of calcined clay cement, geopolymer cement, slag cement, Sorel cement, or calcium aluminate cement. Preferably, cement comprises calcined clay cement or geopolymer cement. Lime may refer to one or more selected types of lime, such as quicklime. In some embodiments, lime comprises one or more selected from the group consisting of quicklime or slaked lime. Gypsum plaster may also be referred to as plaster of Paris, and is a known material in the art, comprising calcium sulphate. Preferably, the binder comprises or consists of gypsum plaster. Surprisingly, it has been found that gypsum plaster is a particularly effective binder for articles and methods of the present invention. The present inventors have found that gypsum plaster can increase method throughput at both the curing and biocalcification steps. Gypsum plaster has been found to exhibit a particularly favourable balance of biocompatibility and fast curing. Other known binders are thought to offer a less favourable balance because curing duration and biocompatibility can be at a trade-off. Without wishing to be bound by theory, it is proposed that known binders may not achieve such a balance due to combinations of less favourable curing time; biocompatibility of conditions for curing (e.g., temperature); biocompatibility of the binder (pH; which may affect bacteria survival); and binder microporosity (when could affect availability of bacteria for the biocalcification step). Gypsum plaster has been found to balance all these considerations in unison, for a particularly fast and reliable method of producing a biocalcified article. AAMs are known in the art and may refer to one or more types of AAM, such as fly ash or diatomaceous earth. In some embodiments, AAM may comprise one or more selected from the group consisting of: fly ash, metakaolin, alkali-activated slag mortar, and diatomaceous earth. Preferably, AAM comprises fly ash. The term “polymerizable material" may refer to any suitable monomer or oligomer for producing a polymer for making the pre-calcified article upon matrix stabilization and hardening. The type of polymer is not particularly limited, and may be synthetic (e.g., petroleum-derived) or a biogenic polymer (e.g., a polysaccharide, which may be derived from algae for example). Synthetic polymerizable materials may be any suitable type, such as an acrylic-type material. For example, in some embodiments polymerizable material may comprise acrylic acid, methacrylic acid, or epoxy acrylate. Accordingly, in some embodiments, the binder may be photoactivatable, for example by ultraviolet irradiation. Biogenic polymerizable materials are known in the art and may comprise a hydrogel or a polysaccharide, such as alginate, pectin, chitosan. Preferably, the biogenic polymerizable material comprises agar. It is understood that agar does not necessarily ‘cure’ or polymerizes according to the same principles as other polymerizable materials. Instead, it is thought that agar may act as a binder upon gelation. Accordingly, when the binder comprises agar, the curing step may instead be replaced by a gelation step. Gelation may comprise cooling the mixture in a mould. In some embodiments, the binder may have a neutral to mildly basic pH, for increasing compatibility of the binder and bacteria present as part of the bacterial inoculant. In other words, the binder may have a biological pH. In some embodiments, the binder may have a pH of 6.5 or more and 10 or less, preferably between 7 or more and 9 or less, more preferably 7 or more and 8.5 or less, most preferably 7 or more and 8 or less. For commercially available binders, a pH may be determined according to a product specification. For any binder, pH may be determined in the usual way, for example by performing a measurement with a pH meter. An amount of binder present as part of the mixture may be defined according to weight. In some embodiments, the binder may be present in an amount of between 3 weight percent (wt%) or more and 66 wt% or less, based on a total weight of the mixture. When the amount of binder is above 3 wt%, it is thought a self-supporting (pre-calcified) article may be more readily formed. When the amount of binder is below 66 wt%, it is thought that a particularly favourable rate of MICP may occur during biocalcification. A risk of adhesion to the mould may also be reduced. When the aggregate consists of inorganic aggregates, the amount of binder is preferably between 3 wt% or more and 18 wt% or less, more preferably between 3 wt% or more and 14 wt% or less, even more preferably between 3 wt% or more and 10 wt% or less, and most preferably between 5 wt% or more and 10 wt% or less. When the aggregate consists of biogenic aggregates, the binder is preferably present in an amount of between 33 wt% or more and 66 wt% or less, more preferably between 33 wt% or more or more and 50 wt% or less, and most preferably between 33 wt% or more and 40 wt% or less. When the aggregate comprises inorganic aggregates and biogenic aggregates, the binder-to-aggregate ratio is preferably between 3 wt% or more and 50 wt% or less, more preferably between 25 wt% or more and 50% or less, and most preferably between 25 wt% or more and 35 wt% or less from a standpoint of compatibilizing the materials for the curing and biocalcification steps. Bacterial Inoculant The bacterial inoculant is not particularly limited in type or format, and suitable inoculants and methods of making inoculants are known in the art. For example, the bacterial inoculant may refer to a bacterial pellet, which may be obtained by culturing bacteria in a medium, and enriching or removing the bacteria, for example by centrifugation. The bacterial inoculant comprises one or more bacteria. “One or more bacteria" refers to a number of species of bacteria, rather than an amount of bacterial cells. At least one of the one or more bacteria is capable of MICP. Preferably, all bacteria present as part of the inoculant are capable of MICP. Such suitable species of bacteria are known in the art. In some embodiments, the one or more bacteria comprise Sporosarcina pasteurii, Bacillus megaterium, Bacillus subtilis, Bactillus licheniformis, Bacillus mucilaginous, Bactillus thuringiensis, Synechocystis sp, Synechococcus sp, Pseudomonas aeruginosa, Escherichia coli, Pseudomonas Stutzeri, Pseudomonas Aeruginosa, and / or Desulfovibrio desulfuricans. Preferably, the one or more bacteria comprise Sporosarcina pasteurii. Without wishing to be bound by theory, it is thought that Sporosarcina pasteurii may exhibit adequate or even favourable rates of MICP during the biocalcification step. In some embodiments, the bacterial inoculant comprises more than one bacteria. In such embodiments, the bacteria preferably comprise a urease-producing bacterium (e.g., Bacillus megaterium), and a carbonic anhydrase-producing bacterium (e.g., Bacillus megaterium), from a standpoint of increasing the rate and amount of MICP in the immersion step. In some embodiments, the bacterial inoculant therefore comprises Sporarcina pasteurii and Bacillus megaterium. In some embodiments, the bacterial inoculant may comprise bacteria powder, bacterial paste, bacterial slurry or bacteria encapsulated by any one of: calcium carbonate, agar, hydrogel, or a polymer substrate. In other words, the bacteria may be provided as part of the inoculant in one or more of the above formats (e.g., a paste). Methods for producing such inoculants are well known in the art and may comprise for example culturing bacteria in one of the above media, or culturing bacteria, filtering the bacteria, and optionally mixing the bacteria with one of the above media. For example, a bacterial paste may be obtained by culturing bacteria until an optical density reaches a predetermined amount, centrifuging the bacteria, and harvesting the centrifuged biomass (e.g., bacterial pellets) comprising the bacteria, and optionally diluting the harvested bacteria. This biomass may comprise residual growth medium, water, the bacteria, and other components and may be used directly (as the bacterial inoculant paste) following centrifugation or may be suspended I diluted (to produce a slurry). Bacteria may be encapsulated by calcium carbonate by performing MICP to produce calcium carbonate particles. The encapsulated bacteria may subsequently be mixed with other components of the mixture. Preferably, the bacterial inoculant comprises calcium carbonate-encapsulated bacteria. In this way, the mixture and pre-calcified article can comprise calcium carbonate particles, which is believed to increase an initial rate and volume of calcification during the immersion step for increasing method throughput. Calcium carbonate-encapsulated bacteria may be present as a bacterial paste, for improved handleability. Said paste may comprise the encapsulated bacteria and water. In some embodiments, the bacterial inoculant is present in an amount of between greater than 0 wt% and 33 wt% or less based on a total weight of the mixture. When the aggregate is inorganic aggregate, the bacterial inoculant is preferably present in an amount of between greater than 0 wt% and 20 wt% or less based on a total weight of the mixture, more preferably in an amount of 5 wt% or more and 15 wt% or less. When the aggregate is biogenic aggregate, the bacterial inoculant is preferably present in an amount of between greater than 0 wt% and 33 wt% or less based on a total weight of the mixture, more preferably in an amount of between 10 wt% or more and 15 wt% or less. In some embodiments, the bacteria are present in the bacterial inoculant in a predetermined amount. In some such embodiments, the bacteria may be present as part of the bacterial inoculant in an amount of from 20* 106 colony forming units (CFU) / mL to 20* 108 CFU / mL. An amount of bacteria (e.g., CFU count) may be measured by known methods, for example by diluting a predetermined mass of the inoculant to a predetermined total volume, and measuring cell count for an aliquot of the diluted inoculant. Supplementary Mixture Components In some embodiments, the mixture may further comprise one or more additives. Additives may be included to adjust the properties of the mixture or article (pre-calcified or biocalcified). For example, a foaming agent may be added to reduce density of the pre-calcified article and / or to improve porosity for improving a rate of MICP. A pH stabiliser may be added to regulate the overall pH of the mixture, to reduce a risk of bacterial cell death prior to the immersion step. A pigment or colourant (e.g., a metal oxide) may be added to control the appearance of the biocalcified article. Fibres (e.g., plant-based fibres and cellulosic fibres such as bagasse fibre, cotton fibre, hemp fibre, miscanthus fibre, jute fibre or paper pulp fibre, or mineral fibres such as glass or clay fibre) may be included to improve durability of the biocalcified article, and / or to improve mechanical properties (including compressive strength, tensile strength, and bending strength). Flame retardants, such as lignin or phosphorus-based flame retardants (e.g., ammonium polyphosphate), may also be added to improve fire resistance. An amount of additives is not particularly limited and may be adjusted depending on the desired properties of the biocalcified articles. In some embodiments, additives may be present in an amount of between greater than 0 wt% and 10 wt% or less, based on a total weight of the mixture. Additionally or alternatively, in some embodiments, the mixture may further comprise a nutrient composition. The term “nutrient composition" refers to a composition for bacteria of the bacterial inoculant to consume for proliferating and metabolising. By providing a nutrient composition in the mixture, bacteria present as part of the bacterial inoculant may proliferate prior to the immersion step, which may further increase an initial rate of MICP. Additionally, in this way and depending on the composition of the mixture, the bacteria may produce calcium carbonate precipitate for increasing an initial rate of MICP during the immersion step (e.g., for acting as a nucleation point). It is known in the art that the components of the nutrient composition can vary depending on the bacterial strain present as part of the bacterial inoculant. In some embodiments, the nutrient composition comprises yeast extract, brewer’s yeast, sodium chloride, ammonium sulphate, dextrose, sucrose, nickel chloride, or a mixture thereof. When the mixture comprises a nutrient composition, the amount is not particularly limited. The nutrient composition may be present in an amount of between 0.05 wt% or more and 4 wt% or less based on a total weight of the mixture. Preferably, the nutrient composition is present in an amount of 1 wt% or more and 2 wt% or less. When an amount of nutrient composition is above 0.05 wt%, the quantity of nutrients may increase a maximum duration for storage of the precalcified article prior to the calcification step. In some embodiments, the mixture may further comprise supplementary calcium carbonate in an amount of between 50 wt% or less, based on a total weight of the mixture. In some embodiments, supplementary calcium carbonate may be present in an amount of 20 wt%, based on a total weight of the mixture. In some embodiments, supplementary calcium carbonate may be present in an amount of between 20 wt% or more and 50 wt% or less, based on a total weight of the mixture. In this way, and as outlined above (e.g., in respect of aggregate comprising limestone and inoculant comprising calcium carbonate-encapsulated bacteria), a rate and amount of MICP during the calcification step may increase, for improving mechanical strength of biocalcified articles and increasing method throughput. When supplementary calcium carbonate is added to the mixture, it is distinct from any calcium carbonate present as part of the bacterial inoculant and aggregate (i.e., calcium carbonate encapsulating bacteria of the inoculant is separate from separate calcium carbonate defined in this paragraph). Supplementary calcium carbonate may have a size according to sizes defined for the aggregate. For example, supplementary calcium carbonate may have a size of below 0.3 mm (e.g., when calcium carbonate dust is used), or between 0.3 mm or more and 40 mm or less. In some embodiments, the mixture may comprise water. The water may be present as part of the bacterial inoculant (e.g., if provided as a slurry or paste) or calcification composition (if present). Supplementary water may also be added, to improve handleability of the mixture for applying the mixture to the mould. An amount of water present as part of the mixture is not particularly limited. Preparing Mixture The mixture may be prepared or provided by mixing the respective components together, for example using a planetary mixture. It is understood that different mixtures may have different formats depending on components used and amounts thereof. For example, some mixtures may be provided as a paste, whereas other mixtures may be provided as a slurry. The format of the mixture may be adjusted by controlling an amount of water present as part of the mixture. Moulding Step After providing the mixture, the mixture is applied to a mould. By applying the mixture to the mould, the mixture can adopt (conform to) the shape of the mould. This process may generally be referred to as moulding or a moulding step. The type of mould is not particularly limited. For example, in some embodiments, the mould may be an extrusion mould, meaning that the mould is suitable for extruding the mixture through for the mixture to adopt a predetermined shape. In other embodiments, the mould may be a press-mould or compression mould. In other embodiments, the mould may be an injection mould, or die casting mould. The mould material is not particularly limited and may be selected to reduce a risk of adhesion between the mould and the mixture during the curing step. As such, in some embodiments the mould may comprise aluminium, steel, plaster of Paris, silicone, tungsten carbide, ceramic, plastic, and / or rubber. When the mould is an extrusion mould, applying the mixture to the mould may comprise extrusion. When the mould is a press-mould or compression mould, applying the mould to the mixture may comprise pressing. Extrusion and pressing processes are known in the art. In some embodiments, the mould may be part of a system further comprising an element for removing the pre-calcified article from the mould. For example, the element may be a pushing rod or pushing plate. In this way, method throughput may be increased. In some embodiments, the mould and mixture may be separated by an interface sheet. The term “interface sheet’ refers to a material which may be deposited on a mould surface for separating the mould surface from the mixture (when the mixture is applied to the mould). When an interface sheet is provided, separation of the mould and pre-calcified article after curing may be more facile. An interface sheet may comprise textile, for example nylon or hessian textile. Preferably, when the moulding step comprises press-moulding, the moulding step comprises depositing an interface sheet on a mould surface for separating the mould surface from the mixture. When an interface sheet is used, the sheet may be separated from the pre-calcified article after the curing step (for example by peeling), or may be integrated with the pre-calcified article. In some embodiments, the mould may comprise a lining layer. The lining layer may function like the interface sheet, more easing separation of the pre-calcified article from the mould after curing. The lining layer may comprise any suitable material, for example rubber, silicone, or polyurethane. Alternatively, the mould may comprise a release layer, comprising a release agent. The release agent may function like the lining layer or interface sheet. It is known in the art that, when a mould comprises a cavity, the mixture can be applied to the cavity. For example, if the mixture is pourable, it may be poured into the cavity, or if the mixture is a paste, it may be pasted or otherwise inserted into the cavity. The mixture may be applied to the mould to partially or completely fill a cavity. In some embodiments, the mixture may be applied to a mould cavity and partially or completely sealed within the cavity, for example using a seal (e.g., a lid). In some embodiments, the moulding step may further comprise vibrating the mixture. Vibration may be performed for example during compression, when the mould is a press mould. Agitation is thought to help distribute the mixture through the mould, possibly increasing method throughput. Equipment for vibrating the mixture is not particularly limited. Curing Step After the mixture is applied to the mould, it is cured to provide a pre-calcified article. This process may be referred to as the curing step. As defined above, curing refers to the process of the binder hardening such that the mixture becomes a self-supporting structure (the precalcified article). The concept of curing is known in the art and generally comprises matrix stabilization of the binder. Depending on the nature of the curing agent, curing (matrix stabilization) may comprise crystallisation and / or polymerisation of the curing agent. Curing is performed until the mixture becomes self-supporting. In other words, it is performed until the moulded mixture can support its own weight under gravity, when removed from the mould. Additional curing of the pre-calcified article may be possible, if the article is self-supporting when not all the binder has hardened and stabilized. In some embodiments, a mixture may be determined to be self-supporting (i.e., curing may be complete, and a pre-calcified article produced) if no visual deformation of the (cured) mixture is observed after removal from the mould. For example, curing may be complete if the cured mixture is removed from a mould, disposed on a surface, and no deformation of the article is visually observed within 5 minutes of deposition on the surface. Alternatively, curing may be complete if deformation below a tolerance threshold occurs after removal of the article from the mould. For example, curing may be complete if a dimension of the pre-calcified article changes by 10% or less when the pre-calcified article is removed from the mould and disposed on a surface. As defined above, the binder should be suitable for curing under conditions which are compatible with survival of the bacteria present as part of the bacterial inoculant (i.e., conditions which are biologically tolerable by said bacteria). In some embodiments, curing may therefore be performed at a “biological temperature", meaning that curing is performed at a temperature biologically tolerable by the bacteria present as part of the bacterial inoculant. In some embodiments, curing may be performed at a temperature of 50 °C or less. For example, the mould may be heated to a temperature of 50 °C or less. In this way, it is thought that curing may be more compatible with the bacteria present as part of the bacterial inoculant. For example, a risk of bacterial cell death may be reduced during curing. In some embodiments, curing may be performed at a temperature of 50 °C or less, preferably 45 °C or less, more preferably 40 °C or less. In some embodiments, curing may be performed at a temperature of 10 °C or more. In this way, it is believed that a curing duration may be reduced, for improving method throughput. In some embodiments, curing may be performed at a temperature of 10 °C or more, preferably 20 °C or more, and more preferably 30 °C or more. For some binders, curing may comprise an initiation step. For example, if the binder comprises acrylic acid, curing may comprise an initiation step comprising irradiating the mixture. Irradiation may be performed with radiation of a suitable wavelength. Curing may be performed for a predetermined duration, to increase method throughput. For curing to be complete within predetermined duration constraints, the binder components and curing step conditions may be fine-tuned. For example, a curing duration may be reduced by using one of the above defined binders and by increasing a curing temperature. A curing temperature may be controlled in the usual way, for example by heating the mixture to a predetermined temperature. In some embodiments, curing may be performed for a duration of 12 hours or less, preferably for a duration of 6 hours or less, more preferably for a duration of 3 hours or less, and most preferably for a duration of 1 hour or less. In some embodiments, curing may be performed for a duration of 6 minutes or more, preferably 10 minutes or more, more preferably, 15 minutes or more, and most preferably 20 minutes or more. In some embodiments, curing may be performed for a duration of between 6 minutes or more and 12 hours or less, preferably between 10 minutes or more and 6 hours or less, more preferably between 15 minutes or more and 3 hours or less, and most preferably between 20 minutes or more and 1 hour or less. Removing from Mould After the mixture is cured to provide a pre-calcified article, the pre-calcified article is removed from the mould. In other words, removal comprises separating the pre-calcified article from the mould. The process of removing the pre-calcified article from the mould may depend on the nature of the mould and moulding process. Appropriate techniques for removing the precalcified article from the mould are routine and are known in the art. For example, for extrusion moulding processes, removing the pre-calcified article from the mould may comprise extrusion. The Pre-calcified Article The pre-calcified article is self-supporting under gravity, and as described above comprises aggregate, a bacterial inoculant, and a cured binder (stabilized and hardened matrix). The precalcified article may be made by applying a mixture to the mould (e.g., applying the mixture to a mould cavity and performing press moulding) and curing the mixture. The components and amounts may be as defined above for the mixture, other than for the cured binder. The cured binder corresponds to the first binder provided as part of the mixture, after curing is performed. For example, when the first binder comprises gypsum plaster, the cured binder comprises cured gypsum plaster, or when the first binder comprises acrylic acid, the cured binder comprises polyacrylic acid. In some embodiments, the pre-calcified article comprises aggregate, wherein the aggregate has a size of between 0.3 mm or more and 40 mm or less. In some embodiments, the pre-calcified article has a cured binder-to-aggregate weight ratio as of 0.03 or more and 2 or less. A cured binder-to-aggregate ratio may be set by setting a corresponding binder-to-aggregate ratio when preparing or providing the mixture. In some embodiments, the pre-calcified article may have a porosity of between from 4% or more and 55% or less or between from 15% or more and 55% or less. Porosity refers to the volume of permeable pore space within an article (compared to the total article volume) and may be measured according to ASTM C642-06. In this way, the biocalcification step duration may be further decreased. It is thought that when a pre-calcified article porosity is between from 4% or more and 55% or less, or between from 15% or more and 55% or less, penetration and transport of nutrients and components for MICP throughout the article may be particularly favourable. Pre-calcified article porosity may be controlled according to several factors, including each of: • using aggregate having a size of between 0.3 mm or more and 40 mm or less (preferably 0.3 mm or more and 24 mm or less for inorganic aggregate, and preferably 3 mm or more and 40 mm or less for biogenic aggregate); • setting a binder-to-aggregate ratio to be 0.03 or more to 2 or less; and / or • using gypsum plaster as the first binder of the mixture. Additional Methods Steps In some embodiments, the method further comprises a post-processing step selected from the group consisting of: washing, polishing, cutting, and machining. Preferably, the method further comprises a washing step. “Washing” refers to the process of rinsing the biocalcified article with water. Washing may be performed by immersing the biocalcified article in a washing tank comprising water, or by spraying the biocalcified article with water. When the method comprises a washing step, a risk of surface irregularities forming after biocalcification may be reduced, because any excess biocalcification solution can be washed from the article. In some embodiments, when performing calcification comprises immersion, the method further comprises sterilising the calcification solution. Sterilisation may be performed prior to or during the immersion step. In this way, any MICP-capable bacteria which are present in the solution (other than those that are present as part of the article) which may be killed. This may reduce an amount of non-productive consumption of components of the calcification solution. Apparatus and methods for sterilising the calcification solution are known to in the art and may comprise for example irradiating the calcification solution with ultraviolet radiation. Sterilization may further comprise filtering the calcification solution, optionally by centrifugal filtration. This may be performed prior to irradiation, to improve irradiation efficacy. In some embodiments, the method further comprises a drying step. Apparatus for drying the biocalcified article are not particularly limited and may comprise heating the biocalcified article to a predetermined temperature. Drying may comprise heating the biocalcified article. The Biocalcified article The biocalcified article refers to the (pre-calcified) article after biocalcification is performed. That is, when an acceptable amount of calcium carbonate has precipitated on the article, the article may be referred to as a biocalcified article. An acceptable amount of calcium carbonate may be precipitated for example when the article meets a minimum threshold of mechanical strength (e.g., compressive strength). The biocalcified article comprises aggregate, a cured binder, and calcium carbonate. At least some of the calcium carbonate is formed by MICP (by biocalcification). In some embodiments, the calcium carbonate may be a calcium carbonate matrix. The term “calcium carbonate matrix" refers to a continuous or semi-continuous network of calcium carbonate formed at least partially by performing biocalcification. In some embodiments, the biocalcified article may comprise aggregate in an amount of 5 wt% or more, preferably 25 wt% or more, more preferably 33 wt% or more, even more preferably 50 wt% or more, based on a total weight of the biocalcified article. In some embodiments, the aggregate may be present in an amount of 97 wt% or less, preferably 85 wt% or less, more preferably 80 wt% or less, based on a total weight of the biocalcified article. In some embodiments, the aggregate may be present in an amount of between 5 wt% or more and 97 wt% or less, based on a total weight of the biocalcified article, preferably between 25 wt% or more and 85 wt% or less, more preferably between 33 wt% or more and 85 wt% or less, even more preferably between 50 wt% or more and 80 wt% or less, most preferably between 50 wt% or more and 80 wt% or less. In some embodiments, the biocalcified article may have a water vapour transmissibility (p) of 17 or less, preferably 16 or less, and more preferably 15 or less when measured according to ISO 12572:2016. Preferably, when the biocalcified article has a water vapour transmissibility of 17 or less, it also comprises aggregate in amounts defined above (e.g., in an amount of between 5 wt% or more and 97 wt% or less), and / or a porosity as defined below. In some embodiments, the biocalcified article may have a porosity of between from 2% or more and 50% or less, wherein porosity is measured according to ASTM C642-06. Preferably, when the biocalcified article has a porosity of between from 2% or more and 50% or less, it also has a water vapour transmissibility of 17 or less, it also comprises aggregate in amounts defined above. In some embodiments, the biocalcified article may comprise spent bacterial inoculant. Second aspect In a second aspect there is provided a method of manufacturing a multilayered article. The method comprises providing or producing a biocalcified article according to the first aspect, coating the biocalcified article with a second mixture, and performing biocalcification. The second mixture may be as defined according to the first aspect but does not necessarily need to comprise a binder. This is because the biocalcified article provided or manufactured is self-supporting. The second mixture is different from the mixture provided for manufacturing or providing the biocalcified article. For example, the (first) mixture may comprise a biogenic aggregate and the second layer may comprise an inorganic aggregate. The resultant multilayered article may consequently have an improved balance of mechanical strength and density, or an improved balance of weight and scratch resistance. In some embodiments, depending on the shape of the multilayered article, the first layer may be an inner layer, and the second layer may be an outer (coating) layer. Performing biocalcification may be as defined according to the first aspect. That is, it may comprise humidification or an immersion step. Third aspect In a third aspect there is provided a biocalcified article. The biocalcified article comprises aggregate, a cured binder, and calcium carbonate. The cured binder may be as defined for the first aspect. At least some of the calcium carbonate is formed by MICP (by biocalcification). In some embodiments, the calcium carbonate may be a calcium carbonate matrix. In some embodiments, the biocalcified article may comprise aggregate in an amount of 5 wt% or more, preferably 25 wt% or more, more preferably 33 wt% or more, even more preferably 50 wt% or more, based on a total weight of the biocalcified article. In some embodiments, the aggregate may be present in an amount of 97 wt% or less, preferably 85 wt% or less, more preferably 80 wt% or less, based on a total weight of the biocalcified article. In some embodiments, the aggregate may be present in an amount of between 5 wt% or more and 97 wt% or less, based on a total weight of the biocalcified article, preferably between 25 wt% or more and 85 wt% or less, more preferably between 33 wt% or more and 85 wt% or less, even more preferably between 50 wt% or more and 80 wt% or less, most preferably between 50 wt% or more and 80 wt% or less. In some embodiments, the biocalcified article may have a water vapour transmissibility (p) of 17 or less, preferably 16 or less, and more preferably 15 or less when measured according to ISO 12572:2016. Preferably, when the biocalcified article has a water vapour transmissibility of 17 or less, it also comprises aggregate in amounts defined above (e.g., in an amount of between 5 wt% or more and 97 wt% or less), and / or a porosity as defined below. In some embodiments, the biocalcified article may have a porosity (permeable void space volume) of between from 2% to 50%, wherein porosity is measured according to ASTM C642-06. When the biocalcified article has a porosity of 2% to 50%, it preferably also has a water vapour transmissibility of 17 or less, and preferably also comprises aggregate in amounts defined above. In some embodiments, the biocalcified article may comprise spent bacterial inoculant. In some embodiments, the biocalcified article may be produced according to the first aspect. In some embodiments, the biocalcified article may be a multilayered biocalcified article comprising a first layer and a second layer, wherein each layer comprises aggregate, a cured binder, and a calcium carbonate matrix, wherein the first layer is different from the second layer. In some embodiments, the biocalcified article may be a multilayered biocalcified article produced according to the second aspect. Fourth aspect In a fourth aspect there is provided a pre-calcified article. The pre-calcified article comprises aggregate, a bacterial inoculant, and a cured binder agent. The cured binder, aggregate, and bacterial inoculant may be as defined for the first aspect. In some embodiments, the pre-calcified article may be produced according to the first aspect. In some embodiments, the pre-calcified article may have a porosity of between from 4% or more and 55% or less, wherein porosity is measured according to ASTM C642-06. In some embodiments, there may be provided a pre-calcified article produced according to the second aspect. Summary of the Figures Embodiments and experiments illustrating the principles of the invention will now be discussed with reference to the accompanying figures in which: Figure 1. Shows a scheme of an embodiment of the method according to the first aspect. Figure 2. Shows a scheme of an embodiment of the method according to the first aspect. Figure 3. Shows a scheme of an embodiment of the method according to the first aspect. Detailed description of the Figures Aspects and embodiments of the present invention will now be discussed with reference to the accompanying figures. Further aspects and embodiments will be apparent to those skilled in the art. All documents mentioned in this text are incorporated herein by reference. Figure 1 shows a scheme of an embodiment of the method according to the first aspect. In a first step, a bacterial inoculant, aggregate and binder are mixed to form a mixture. The bacterial inoculant comprises bacteria capable of performing MICP (e.g., Sporsarcina pasteurii). The mixture is in the form of a paste but may vary in consistency depending on the components present as part of the mixture and amounts thereof. For example, the mixture may alternatively be a freeze-dried powder comprising dormant bacteria. The paste is applied to press-mould and pressed to conform to a particular shape. It may also be applied to an extrusion mould an extruded to adopt a predetermined form. After application to the mould, the mixture is cured. The binder is selected for curing under ambient conditions (at room temperature and pressure), but the binder may also be selected for binding at a different biological temperature. After matrix formation and stabilization, the pre-calcified article is formed (e.g. curing is complete). The article is visually observed to be self-supporting, and is immersed in a tank comprising calcification solution. The calcification solution comprises nutrients (yeast extract) and a source of calcium ions (calcium chloride) for the bacteria to perform MICP and proliferate. The calcification may also comprise urea, particularly when the bacterial inoculant comprises a urease-reducing bacterium. During the immersion step, calcium carbonate precipitates on the article, increasing the article weight and strength. When immersion is complete, the biocalcified article is removed from the tank and is rinsed by immersion in a water tank to remove excess calcification solution. After immersion in the water tank, the article is removed and dried (e.g., in a temperature-controlled chamber). The article may be washed to remove excess calcification solution and subjected to additional post-processing steps. Figure 2 shows a scheme of an embodiment of the method according to the first aspect. The method is like for the scheme of Figure 1 but differs in that the immersion step is repeated at least once, and in that immersion is performed at a depth of 50 cm or more for increasing the hydrostatic pressure on the article. A washing step and drying step is performed. Figure 3 shows a scheme of an embodiment of the method according to the first aspect. The method is like for the schemes of Figures 1 and 2 but differs in that all components for the curing step and for the calcification step are provided as part of the mixture. Additionally, after curing, the pre-calcified article is inserted into a humidity-controlled chamber, rather than being immersed in a calcification solution. The chamber is below its dew point, so that calcium chloride can precipitate on the article, consuming the calcium source and nutrients provided as part of the mixture. Calcification is performed until the amount of precipitated calcium carbonate is acceptable. Afterwards, the article is removed from the chamber, and may be subjected to post-processing (e.g., cutting). Extent of disclosure The features disclosed in the foregoing description, or in the following claims, or in the accompanying drawings, expressed in their specific forms or in terms of a means for performing the disclosed function, or a method or process for obtaining the disclosed results, as appropriate, may, separately, or in any combination of such features, be utilised for realising the invention in diverse forms thereof. While the invention has been described in conjunction with the exemplary embodiments described above, many equivalent modifications and variations will be apparent to those skilled in the art when given this disclosure. Accordingly, the exemplary embodiments of the invention set forth above and below are considered to be illustrative and not limiting. Various changes to the described embodiments may be made without departing from the spirit and scope of the invention. For the avoidance of any doubt, any theoretical explanations provided herein are provided for the purposes of improving the understanding of a reader. The inventors do not wish to be bound by any of these theoretical explanations. Any section headings used herein are for organizational purposes only and are not to be construed as limiting the subject matter described. Throughout this specification, including the claims which follow, unless the context requires otherwise, the word “comprise” and “include”, and variations such as “comprises”, “comprising”, and “including” will be understood to imply the inclusion of a stated integer or step or group of integers or steps but not the exclusion of any other integer or step or group of integers or steps. It must be noted that, as used in the specification and the appended claims, the singular forms “a,” “an,” and “the” include plural referents unless the context clearly dictates otherwise. Ranges may be expressed herein as from “about” one particular value, and / or to “about” another particular value. When such a range is expressed, another embodiment includes from the one particular value and / or to the other particular value. Similarly, when values are expressed as approximations, by the use of the antecedent “about,” it will be understood that the particular value forms another embodiment. The term “about” in relation to a numerical value is optional and means for example +1-10%. Examples Materials and methods Materials for preparing articles were obtained as follows: Component Description Inorganic aggregates Limestone aggregate and Granite aggregate having a size of 4 mm or less were supplied from ‘Loads of Stone’, Darlinton, UK (‘Limestone Dust’ and ‘Granite dust’ products). Biogenic aggregates Hemp Hurds (Hemp Shiv) having a size of 22 mm were supplied from ‘La Chanvriere’, France. Binder Gypsum plaster was supplied from Saint Gobain. Calcium acetate 99% purity from APC chemicals; pulverised in a high shear mill to a fine powder. Prilled urea 99.3% purity from Mistral Industrial Chemicals, pulverised in a high shear mill to a fine powder. Bacterial Inoculant Preparation Bacteria are cultured in a suitable medium and at biological conditions until a desired Optical density and enzymatic activity is observed. In general, the bacteria (e.g., Sporosarcina pasteurii, and / or other species) can be cultured using a media composition comprising yeast extract at a concentration of 20 g / L, (NH4)2(SO4) at a concentration of 10 g / L, tris(hydroxymethyl)aminomethane at a concentration of 12 g / L, and urea at a concentration of 20 g / L, until an optical density is between 0.7-1.0 ODeoo as measuring using a spectrophotometer (set to measure a wavelength of 600 nm). After culturing, the bacteria are stored as the full-volume culture at 4 °C for up to one week or are immediately separated from the medium. The bacteria can be separated from the medium by centrifugation (flow or batch methods, or a combination thereof). For example, for a combination method a peristaltic pump is used to transfer the culture medium comprising cultured bacteria into a domestic centrifuge suitable for separating cream from milk, at a rate of between 3-5 Litres per hour. The centrifuge is set to 12,000 rpm to separate the bacteria cells from the culture medium. After separation, the bacteria are removed and washed with approximately 100 mL water per 3-5 Litres of initial culture medium (pre-centrifugation) to provide a bacteria paste or slurry. A Haeraus Megafuge 2.Or batch centrifuge set to 6,000 rpm for 15 minutes was used to separate residual liquids from the bacteria, to produce a bacteria plug. For incorporation into a mixture, the bacterial plug can be suspended in water at a concentration 5 times an initial culture concentration. For example, for bacteria cultured to 0.7-1.0 ODeoo in a culture medium of 3 Litres, a bacteria plug produced by the above process is suspended in 600 mL to provide a bacterial slurry or paste. The cultured bacteria may alternatively be freeze-dried or stored at low temperature (e.g., under refrigeration), for example with glycerol depending on the storage temperature. Alternatively, the full bacteria culture is combined with nutrients and a calcification composition (for example comprising calcium chloride and urea). They can additionally be mixed with some aggregate (e.g., fine limestone powder), for coating the aggregate. The bacteria can adhere to the powder, for separation after settling or by centrifugation. The bacterial inoculant used for the mixture has a cell count of approximately from 1x108 to 2x108 CFU / mL when CFU is measured. CFU is measured by serial dilution of the bacterial inoculant using known methods. For example, it is measured by diluting the bacterial inoculant with water to 1xio-1, 1xio-2, 1x10-3, 1x10-4, 1xio-5, and 1x10-6, of the initial concentration. A 100 pL aliquot is independently taken from each of the diluted solution and respectively applied to an agar plate of a suitable medium comprising around 13 g / L yeast extract for incubation at 24-48 hours at 30 °C, until colonies are formed. The cultured agar plate with visible, discrete (separate) colony formations is selected and the number of colonies is counted for determining CFU of the corresponding inoculant. For example, S. Pasteurii cultured to an optical density of ODeoo = 0.7 are found to have a CFU of around 20x106 / mL, which may correspond to a bacterial inoculant CFU of around 2x108 / mL for inoculants concentrated by a factor of 10 times. Compressive Strength Compressive strength is measured following ASTM C39 except that test cylinder samples have a diameter of 35 mm and a height of 70 mm. Compressive strength tests are performed in triplicate, and a mean compressive strength values is determined. Mixture For preparing the mixture, the following mixers are used: Kenwood A701, Hobart A200, or Baron F120. Drum mixers, high shear mixers, forced action mixers or other types may be used. Mould For compression moulding, an HDPE mould having A4 length and width (297 mm and 210 mm respectively) and thickness of 25 mm is provided. The mould comprises a rectangular sleeve having two pairs of opposing sides, one pair of sides each having dimensions 297 x 25 mm and another pair of sides each having dimensions 210 x 25 mm, and a top plate sheet and a bottom plate each having dimensions 210 x 297 mm. The bottom plate is disposed on a surface and the sleeve is engaged with the bottom plate to define a cavity, and the mixture is applied to the cavity to fully cover the bottom plate. The top plate is disposed onto the mixture and engaged with the sleeve to seal the mixture in the mould. A steel frame is then used for biasing the top plate towards engagement with the sleeve during moulding and curing. A panel-shaped precured article is provided upon curing, having dimensions of 210 mm x 297 mm, and a predetermined thickness. To adjust panel thickness, an insert of predetermined thickness is disposed into the cavity (onto the bottom plate) before applying the mixture. Curing step For curing, mixture is kept at ambient temperature in the mould, as described for Examples 1 to 5 below, until the mixture is self-supporting under gravity (until a pre-calcified article is formed). For immersion, a 30 Litre HDPE immersion tank is used. The tank includes a temperature control system for setting a temperature during biocalcification, and a circulation pump for agitating the calcification solution. Unless otherwise stated, the calcification solution for immersion is an aqueous solution of UV-sterilised municipal water with 0.5 M CaCh, 0.5 M urea, and 3 g / L yeast extract. For humidification, a 100 Litre Perspex chamber including a temperature-regulation system and a humidity control system (for adjusting a relative humidity of the chamber) is used. The humidity control system includes a water source (e.g., a water tank or tray). EXAMPLE 1 - Mineral Aggregate Article and Immersion Method Sporosarcina Pasteurii DSMZ 33 is cultured at 30 °C using a culture medium as described above for ‘bacterial inoculant preparation’. The bacteria are cultured for around 24 hours, until an optical density of ODeoo is around 0.8. After centrifugation, the bacteria are suspended in water to be at a concentration of 5 times the original culture concentration (CFU = 1*108 / mL), to provide the bacterial inoculant. Limestone aggregate having a size of between 0.9 mm and 2.5 mm is prepared by sieve grading according to BS EN 933 [part 1], to remove 99% of aggregate material having a size below 2.5 mm (aggregate with a size error of 1% is used). Gypsum plaster is used as the binder. The binder and aggregate are mixed using a Kenwood A701 stand mixer at medium speed with a paddle mixing attachment, until the components are homogeneous. Afterwards, bacterial inoculant and deionized water (separate from that provided as part of the inoculant) are added and the mixture is stirred until homogeneous by visual inspection. The mixture is according to the following Table: Component (details; function) wt% (based on a total weight of the mixture) Limestone aggregate (2.5mm to 4mm) 86.3% Gypsum plaster binder 6% Sporosarcina pasteurii DSMZ 33 bacterial inoculant (5x culture concentration in deionised water) 3.5% Deionised water 4.2% The mixture is applied to an A4-size sheet mould as described above. Two nylon textile interface sheets are used for separating the mixture from the mould. One is applied to the bottom plate of the mould, before applying the mixture to the mould, and another is applied to separate the mixture from the top plate. Before application of the second interface sheet, he applied mixture is raked for evenly distributing the mixture across the mould cavity (demarcated by the bottom plate and sleeve). The mould top plate is engaged to encase the mixture, and the filled mould is transferred to a hydraulic press and compressed to a thickness of 12 mm, using up to 2000 N force across the top plate. After compression to 12 mm thickness, the mould is removed from the press and left for 3 hours, for curing. After curing, the pre-calcified article is removed from the mould by first removing the mould sleeve and then separating the interface sheets and plates. The article is allowed to cure further for 1 hour, but this step is optional, because the article is already self-supporting and ready for biocalcification. For immersion, a 10 Litre calcification solution is prepared using the HDPE immersion tank described above. The calcification solution has 0.5 M calcium chloride, 0.5 M urea, 3 g / L yeast extract, and UV-sterilised municipal water. The calcification solution is heated to 30 °C. The precalcified article is fully submerged (immersed) in the calcification solution and is disposed on a rack for separating the article from the base of the tank. Immersion is performed for 24 hours, and then the article is removed from the tank, rotated 180° about a horizontal axis, and immediately re-submerged to continue immersion for 48 hours, to afford a biocalcified article. The biocalcified article is removed from the calcification solution and fully immersed in a 10 Litre water bath for 24 hours for removing excess calcification solution. The water of the water bath is circulated for 10 minutes of every hour with a circulation pump. Afterwards, the article is removed from the bath and dried at room temperature until a steady weight is reached. Example 2 - Biogenic aggregate Article and Immersion Method Example 2 is prepared as Example 1, except for the differences outlined below. The mixture includes biogenic aggregate (Hemp hurds) and inorganic aggregate (limestone), and is according to the following Table: Component (details; function) wt% (based on a total weight of the mixture) Hemp hurds (biogenic aggregate; 22mm) 23% Limestone Fines (< 0.3 mm; bulks out the binder) 30% Gypsum plaster binder 16% Sporosarcina pasteurii DSMZ 33 bacterial inoculant, (5x culture concentration in deionised water) 7% Deionised water 24% For preparation of the mixture, hemp hurds, limestone fines, and the binder are mixed before adding the bacterial inoculant and deionised water. For moulding, the mixture is pressed at 500 N force across the top plate. After compression to 12 mm thickness, the top mould plate is locked to the sleeve and the mould is removed from the press and left for 8 hours, for curing. The pre-calcified article is then removed from the mould. The pre-calcified article is buoyant in water so, for immersion, the article is restrained to prevent surfacing in the calcification solution. Immersion is performed as described for Example 1, with optional washing in a water bath for 24 hours to remove excess calcification solution. After immersion and optional washing, the article is optionally sanded on at least one face to smooth the surface. Example 3 - Multilayered Article and Immersion Method Example 3 is prepared as Example 1, except for the differences outlined below. Two mixtures are prepared. The first mixture is as defined above for Example 2. The second mixture includes inorganic limestone aggregate, and is according to the following Table: Component (details; function) wt% (based on a total weight of the mixture) Limestone aggregate (0.9 mm to 2.5 mm) 86.3% Gypsum plaster binder 6% Sporosarcina pasteurii DSMZ 33 bacterial inoculant (10x culture concentration in deionised water) 2.5% Deionised water 5.2% The second mixture is applied to the mould, in contact with an interface sheet disposed on the bottom plate, to provide a first layer. The first layer is raked to evenly distribute the mixture across the mould cavity (defined by the sleeve and bottom plate). The first mixture is then applied onto the first layer to provide a second layer. The second layer is raked to evenly distribute the mixture across the first layer. For moulding, the mixture was pressed at 500 N force across the top plate. After compression to 16 mm thickness, the mould is removed from the press and left for 5 hours, for further curing. The multilayered pre-calcified article is then removed from the mould, and immersion is performed as described above for Examples 1 and 2. Example 4 - Inorganic Aggregate, Encapsulated Bacteria, and Humidification Method Bacteria (S. Pasteurii) are cultured at 30 °C as described for Example 1, except that the media composition comprises yeast extract at a concentration of 20 g / L, (NH4)2SO4 at a concentration of 10 g / L, tris(hydroxymethyl)aminomethane at a concentration of 14 g / L, and urea at a concentration of 20 g / L. After culturing to an optical density (ODeoo) of 0.8, the bacteria are added to a calcification solution including 0.33 M calcium chloride, 0.33 M urea, and 5 g / L yeast extract. The calcification solution is set to 30 °C for 100 hours and is agitated by bubbling with air. Afterwards, bubbling is stopped, and solids are sedimented over a period of up to 8 hours. Then, around 95% of the solution is removed to provide a bacterial inoculant paste consisting of around 40% liquids by weight and 60% solids by weight. The bacterial inoculant is a paste comprising calcium carbonate-encapsulated bacteria and spent biocalcification solution. The mixture includes aggregate, a calcification composition (comprising calcium acetate, urea, and nutrients), and the above bacterial inoculant. In this example, bacterial inoculant also functions as a binder, so additional binder (e.g., gypsum plaster) is not provided. The mixture is according to the following table: Component (details; function) wt% (based on a total weight of the mixture) Bacterial inoculant paste (comprising calcium carbonate-encapsulated bacteria; functioning as bacterial inoculant, binder, and supplementary CaCOs) 30% Gypsum binder 7% Limestone (up to 2.5 mm) 50% Calcium acetate 3% Urea 3% Nutrients (sterile yeast extract media 10 g / L yeast extract, 5 g / L (NHshSCL, and 14g / L tris(hydroxymethyl)aminomethane buffer] 7% For moulding, the top plate is not used. When applying the mixture to the mould, the mixture is allowed to settle to adopt the shape of the cavity under gravity, optionally with vibrational agitation. The mixture is cured in the open-top mould at 30 °C for 3 hours. The article is then removed from the mould and deposited in a humidity-controlled chamber at 23 °C and 80-100% relative humidity for 48 hours to perform biocalcification. Afterwards, the biocalcified article is washed in a water bath for 24 hours and dried as described for Example 1. Example 5 - Inorganic Aggregate, Encapsulated Bacteria, and Immersion Method A mixture is provided and cured as described for Example 4. After curing is complete, immersion, washing, and drying performed as described for Example 1 except that the calcification solution includes 0.5 M calcium chloride, 0.5 M urea, and 1 g / L yeast extract. Method Throughput The duration of each step for each exemplary article is as shown in the following Table: Example 1 2 3 4 5 Curing duration (in mould) / hours 3.0 8.0 5.0 3.0 3.0 Biocalcification duration / hours 24 24 24 48 24 COMPARATIVE EXAMPLE 1 A biocalcified article is prepared according to a known process. Bacteria are cultured as described for the above Examples 1-5, using a culture medium with 20 g / L yeast extract, 20 g / L urea, and a tris(hydroxymethyl)aminomethane-HCI buffer for maintaining the culture at a pH of 7.5-8.0. The culture is grown at 30 °C using a shaker incubator set to 200 rpm. Bacteria are cultured until an optical density of ODeoo = 0.7-1.0 is measured. Known construction sand (size = 0.1 mm or greater) is used, after washing and oven drying. The sand aggregate is packed into a known PVC tubular mould 30 mm in diameter and 80 mm in length, capped at a first end and a second end. Each end cap includes an element for functioning as an inlet and outlet, depending on a direction of flow of liquid. The inlet / outlet elements each respectively include a hose barb for attaching a tube. Sand is packed into the mould to provide a 3 mm separation volume between the sand and each cap. A perforated plate occupies each separation volume and is used for promoting even penetration of fluid flowing between the element and sand proximal to the element. Filter paper is applied to a surface of each perforated plate to prevent sand from passing through. For subsequent steps, the mould is temperature controlled at 30 °C. The mould is connected to tubes, which are connected to pumps (e.g., peristaltic pumps) for fluid flow. The mould is oriented vertically, whereby fluid can flow between each element (one functioning as an inlet and the other as an outlet) in an axis coincident with the direction of gravity. The cultured S. Pasteurii is pumped through the mould to saturate the aggregate with liquid culture and introduce bacteria. After pumping, incubation is performed for 2-12 hours. After incubation, a calcification solution comprising 0.5 M CaCh, 0.5 M urea, and 3 g / L yeast extract is pumped into the mould in 10 intervals across 4 hours. The mould is then inverted for reversing the flow of fluid in subsequent steps. The aggregate is reinoculated with bacteria as described above, and a calcification solution is pumped into the mould in 10 intervals across 4 hours to afford a biocalcified article. Water is subsequently pumped through the mould to remove excess calcification solution and ammonia. The biocalcified article may then be removed from the mould. In this example, the aggregate occupies the mould for around 92 hours. In this method, clogging is observed in the elements (inlet / outlet), tubes, and pumps (from bacteria that are dislodged, and from MICP produced by the dislodged bacteria). Mould rupturing is also observed and is believed to result from fluid pressure build-up associated with the inlet / outlet clogging. Unreliable calcification (MICP) is consequently observed. An uneven distribution of MICP is also observed across the length of the article due to variations in the rate of biocalcification. Articles produced by this method are found to have uneven compressive strength across a length of the article. References A number of publications are cited above in order to more fully describe and disclose the invention and the state of the art to which the invention pertains. Full citations for these references are provided below. The entirety of each of these references is incorporated herein. WO 2023 / 099925

Claims

1. A method of manufacturing a biocalcified article, the method comprising:providing a mixture comprising: aggregate, a first binder, and a bacterial inoculant; applying the mixture to a mould;curing the mixture to provide a pre-calcified article;removing the pre-calcified article from the mould; and performing biocalcification to provide a biocalcified article.

2. A method of manufacturing a biocalcified article according to claim 1, wherein performing biocalcification comprises immersing the pre-calcified article in a calcification solution.

3. A method of manufacturing a biocalcified article according to claim 1, wherein: performing biocalcification comprises humidification.

4. A method of manufacturing a biocalcified article according to any one of the preceding claims, wherein the first binder and the one or more aggregates are present in a binder-to-aggregate weight ratio of between from 0.03 or more to 2 or less.

5. A method of manufacturing a biocalcified article according to any one of the preceding claims, wherein the aggregate comprises:one or more inorganic aggregates selected from the group consisting of: sand, gravel, stone, concrete, ceramic, marine shells, or olivine; and / orone or more biogenic aggregates selected from the group consisting of: barley straw, oat straw, wheat straw, soy bean straw, miscanthus straw, rapeseed straw, rye straw, legume straw, millet stalks, cotton stalks, cotton seeds, rice husk, hemp hurds, sunflower husk, wheat husk, barley husk, maize stalks, maize cob, coconut shell, coconut haulm, soy bean hulls, sugarcane bagasse, coconut husk, wood chips, wood shavings, vine pruning, and sawdust; and / orone or more selected from the group consisting: of paper and textiles.

6. A method of manufacturing a biocalcified article according to any one of the preceding claims, wherein the aggregate comprises one or more inorganic aggregates selected from the group consisting of: sand, gravel, stone, concrete, ceramic, marine shells, or olivine, wherein the one or more inorganic aggregates have a size of between from 0.3 mm or more and 24 mm or less.

7. A method of manufacturing a biocalcified article according to claim 6, wherein the aggregate comprises limestone.

8. A method of manufacturing a biocalcified article according to any one of the preceding claims, wherein the aggregate comprises one or more biogenic aggregates selected from the group consisting of: barley straw, oat straw, wheat straw, soy bean straw, miscanthus straw, rapeseed straw, rye straw, legume straw, millet stalks, cotton stalks, cotton seeds, rice husk, hemp hurds, sunflower husk, wheat husk, barley husk, maize stalks, maize cob, coconut shell, coconut haulm, soy bean hulls, sugarcane bagasse, coconut husk, wood chips, wood shavings, vine pruning, and sawdust, wherein the one or more biogenic aggregates have a size of between from 3 mm or more and 40 mm or less.

9. A method of manufacturing a biocalcified article according to any one of the preceding claims, wherein the binder comprises gypsum plaster.

10. A method of manufacturing a biocalcified article according to any one of the preceding claims, wherein the mixture further comprises supplementary calcium carbonate, optionally wherein the supplementary calcium carbonate is present in an amount of between 20 wt% or more and 50 wt% or less, based on a total weight of the mixture.

11. A method of manufacturing a biocalcified article according to any one of the preceding claims, wherein the bacterial inoculant comprises or more bacteria for microbially induced calcium carbonate precipitation.

12. A method of manufacturing a biocalcified article according to claim 11, wherein the one or more bacteria comprise a urease-producing bacterium and a carbonic anhydrase-producing bacterium.

13. A method of manufacturing a biocalcified article according to claim 11 or 12, wherein the one or more bacteria comprises Sporosarcina pasteurii, Bacillus megaterium, Bacillus subtilis, Bactillusc, Bactillus licheniformis, Bacillus mucilaginous, Bactillus thuringiensis, Synechocystis sp, Synechococcus sp, Pseudomonas aeruginosa, Escherichia coli, Pseudomonas Stutzeri, Pseudomonas Aeruginosa, and / or Desulfovibrio desulfuricans.

14. A method of manufacturing a biocalcified article according to claim 11 or 13, wherein the one or more bacteria is Sporarcina Pasteurii.

15. A method of manufacturing a biocalcified article according to claim 12 or 13, wherein the one or more bacteria comprise Sporarcina Pasteurii and Bacillus megaterium.

16. A method of manufacturing a biocalcified article according to any one of the preceding claims, wherein the bacterial inoculant is present in an amount of greater than 0 wt% and 33 wt% or less based on a total weight of the mixture.

17. A method of manufacturing a biocalcified article according to any one of the preceding claims, wherein the binder has a pH of 6.5 or more and 8.5 or less.

18. A method of manufacturing a biocalcified according to any one of the preceding claims, wherein immersing the biocalcified article in a calcification solution is performed until a weight of the article increases by an amount of 5% or more, based on a dry weight of the pre-calcified article.

19. A method of manufacturing a biocalcified article according to any one of the preceding claims, wherein the calcification solution comprises nutrients and a calcium ion source.

20. A method of manufacturing a biocalcified article according to claim 19, wherein the calcium ion source comprises a calcium salt, optionally wherein the calcium salt comprises calcium chloride, calcium acetate, and / or calcium lactate.

21. A method of manufacturing a biocalcified article according to claim 19 or 20, wherein the nutrients comprise yeast extract, brewer’s yeast, sodium chloride, ammonium sulphate,dextrose, sucrose, nickel chloride, or a mixture thereof, optionally wherein the nutrients comprise yeast extract.

22. A method of manufacturing a biocalcified article according to any one of claims 19 to 21, wherein the calcification solution comprises:nutrients at a concentration of 20 g / L or less and 0.05 g / L or more; and / ora calcium ion source at a concentration of 0.01 M or more and 1.2 M or less.

23. A method of manufacturing a biocalcified article according to any one of the preceding claims, wherein the mixture further comprises a calcification composition.

24. A method of manufacturing a multilayered biocalcified article, the method may comprise: providing a first mixture comprising: aggregate, a first binder, and a bacterial inoculant; providing a second mixture comprising: aggregate, a second binder, and a bacterial inoculant; wherein the second mixture is different from the first mixture;applying the first mixture to a mould to provide a first layer;applying the second mixture to the first layer to provide a second layer;curing the mixtures to provide a pre-calcified article; removing the pre-calcified article from the mould; and performing biocalcification to provide a multilayered biocalcified article.

25. A biocalcified article produced according to any one of claims 1 to 23, or a multilayered biocalcified article produced according to claim 24.

Citation Information

Patent Citations

  • ViewUS2022/0144702A1onEspacenetopensinnewtab

  • ViewUS2018/0072632A1onEspacenetopensinnewtab